Background
==========

In the USA, 6 million patients present to emergency departments with chest pain each year, at an annual cost of \$8 billion \[[@B1],[@B2]\]. In emergency departments, roughly 60% to 90% of the patients presenting with chest pain have no underlying cardiovascular disease \[[@B3]-[@B6]\]. The proportion of patients with cardiovascular disease may be higher in specialized units (cardiology emergency departments, cardiac care units (CCUs), intensive care units (ICUs)) \[[@B7]\] and lower in the primary care setting \[[@B6],[@B8]-[@B10]\]. Physicians generally assume that patients with non-cardiovascular chest pain (NCCP) have an excellent prognosis after ruling out serious diseases. However, patients with NCCP have a high disease burden; most patients that seek care for NCCP complain of persisting symptoms on 4-year follow-up \[[@B11]\]. Furthermore, compared to patients with cardiac pain, patients with non-cardiac chest pain have a similarly impaired quality of life and similar numbers of doctor visits \[[@B12]\].

In patients with chest pain, the diagnostic investigation focuses primarily on cardiovascular disease diagnosis and is often performed by cardiologists. Upon ruling out cardiovascular disease, only vague recommendations exist for further diagnostic investigation, often delaying diagnosis and appropriate treatment and causing uncertainty for patients \[[@B13]\]. Limited data are available regarding efficient diagnostic investigations for patients with NCCP. Most studies investigate gastrointestinal diseases, and extensive provocation testing has been proposed \[[@B14]\]. Some report that almost half of the patients with NCCP will have gastrointestinal disorders \[[@B12]\], while others attribute more than a third of cases to psychiatric disorders, as diagnosed by the *Diagnostic and Statistical Manual of Mental Disorders*, fourth edition (DSMIV). Referred pain from the spine and the chest wall are also likely substantial contributors to NCCP. Information is scarce regarding the appropriate diagnostic tests, and their sensitivity and specificity to discriminate different non-cardiac diseases.

The present systematic review aimed to identify relevant diagnostic tests for patients with NCCP, and to summarize their positive and negative likelihood ratios for underlying disease identification.

Methods
=======

Literature search and study selection
-------------------------------------

This review, conducted in May 2012, followed the QUADAS quality assessment checklist for diagnostic accuracy studies \[[@B15]\]. We searched six databases (PubMed/Medline, Biosis/Biological Abstracts (Web of Knowledge), Embase (OvidSP), INSPEC (Web of Knowledge), PsycInfo (OvidSP), and Web of Science (Web of Knowledge)) using the following search terms as medical subject headings (MeSH) and other subject headings: thoracic pain, chest pain, non-cardiac chest pain, atypical chest pain, musculoskeletal chest pain, esophageal chest, and thoracic spine pain. The findings were limited to studies investigating 'diagnosis', 'sensitivity and specificity', 'sensitivity specificity', or chest pain/diagnosis. We applied no limits for study setting or language; however, one potentially eligible Russian language article was excluded due to lack of language proficiency \[[@B16]\]. Appendix 1 depicts three detailed search strategies.

To ensure search completeness, one reviewer (MW) conducted a hand search of the last 5 years in the four journals that published most articles about patients with NCCP (*Gastroenterology*, *Chest*, *Journal of the American College of Cardiology* and *American Journal of Cardiology*). Potentially eligible references not retrieved by the systematic search in the six databases were added. Bibliographies of included studies were also searched, and potential eligible references included in the full text review.

Eligibility criteria
--------------------

Eligible studies included non-screening studies on diagnostic accuracy published between 1992 and May 2012. Inclusion criteria were studies reporting on patients of 18 years and older, seeking care for NCCP. NCCP was defined as chest pain and cardiac or other vascular disease was ruled out (that is, cardiovascular disease, aortic dissection, pulmonary embolism). Exclusion criteria included studies with \<30 patients per group due to concerns about sample size \[[@B17]\]. This group size was arbitrarily chosen to exclude studies with the highest risk of bias, while allowing a comprehensive literature overview. Based on the nomogram proposed by Carley *et al*. a sample size of more than \>150 patients are needed to accurately assess a diagnostic test \[[@B18]\]; however, with this sample size cut-off, very few studies (mainly retrospective data analyses) would have been eligible.

Study selection, data extraction, and synthesis
-----------------------------------------------

Two reviewers (MW and KR) independently screened 6,380 references by title and abstract. Both reviewers independently reviewed the full text of 260 studies meeting the eligibility criteria. Disagreements were discussed and resolved by consensus or third party arbitration (JS). Researchers with specific language proficiencies reviewed non-English language references. When the same study was included in several publications without change in diagnostic measure, the most recent publication was chosen and missing information was added from previous publications.

All information regarding the diagnostic test, reference test, and considered differential diagnosis was extracted and grouped according to the disease investigated. The methods used to assess accuracy, sensitivity, and specificity were also extracted.

Quality assessment
------------------

Study quality was assessed using the Scottish Intercollegiate Guidelines Network (SIGN) methodology checklist for diagnostic studies \[[@B19]\]. Overall bias risk and study quality was rated according to the SIGN recommendations. The ratings included high quality (++; most criteria fulfilled and if not fulfilled, the study conclusions are very unlikely to be altered), moderate quality (+; some criteria fulfilled and if not fulfilled, the study conclusions are unlikely to be altered), low quality (−; few or no criteria fulfilled, conclusions likely to be altered). Studies rated as low quality by both reviewers were excluded from further analysis.

Reference standards and test evaluation
---------------------------------------

Information about method validity, reliability, practicability and value for clinical practice of the reference and the standard test was extracted and critically assessed. When several reference standards were used, all measurements were extracted and used for further analysis.

Statistical analysis
--------------------

Descriptive statistics were used to summarize findings across all diagnostic studies. Sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively), and positive and negative likelihood ratios (LR + and LR-, respectively) were calculated based on a 2 × 2 table (true/false positives, true/false negatives). Pretest probabilities (prevalence) and the positive and negative post-test probability of the disease were calculated. If one field contained the value 0, 0.5 was added to each field to enable value calculation. Test diagnostic accuracy was assessed as follows \[[@B20]\]: very good (LR+ \>10, LR- \<0.1); good (LR + 5 to 10, LR- 0.1 to 0.2); fair (LR + 2 to 5, LR- 0.2 to 0.5); or poor (LR + 1 to 2, LR- 0.5 to 1).

When more than four unbiased studies were available in clinically similar populations and with comparable index and reference tests, we performed joined meta-analysis of the diagnostic test sensitivity and specificity. We used a hierarchical Bayesian model, as proposed by Rutter and Gatsonis \[[@B21]\], which accounts for the within-study and between-study variability and the potentially imperfect nature of the reference test. The hierarchical Bayesian model was set up as follows: we assumed *J* diagnostic studies in the meta-analysis, with crosstabulation between index test (*T1*) and reference test (*T2*) available for each study, and both tests assumed to be dichotomous (1 = positive test result, 0 = negative test result). Each study was assumed to use a different cut-off value (θ~j~) to define a positive test result. The diagnostic accuracy of each study was denoted by α~j~. The model structure implied a within-study level for study-specific parameters (θ~j~ and α~j~), and a between-study level for parameters common among all studies. The model could theoretically be extended to include study-specific covariates such as percentage of female patients or mean age to reduce heterogeneity on study level.

Appendix 2 gives details of the model set up and prior distributions. The results of the Bayesian analysis are samples from the posterior distribution of the parameters, and estimates are presented as posterior means (50% quantile), and lower (2.5% quantile) and upper (97.5% quantile) bounds, resulting in a 95% credible region. Analyses were performed using R statistical software and the 'HSROC' package \[[@B22],[@B23]\].

Ethics statement
----------------

For this study no ethical approval was required. No protocol was published or registered. All methods were determined a priori.

Results
=======

Study selection
---------------

Figure [1](#F1){ref-type="fig"} summarizes the search and inclusion process. Out of 6380 records, 260 were reviewed in full text, resulting in exclusion of 232 studies. In total, the analysis included 28 studies. The reasons for exclusion of the 232 studies are given in Figure [1](#F1){ref-type="fig"} and overview of excluded studies reviewed in full text is give in Appendix 3.

![Study flow.](1741-7015-11-239-1){#F1}

Study characteristics
---------------------

Table [1](#T1){ref-type="table"} presents the study characteristics, and included patients. In all, 20 studies (71%) evaluated diagnostic tests to identify gastrointestinal disease, mainly gastroesophageal reflux disorders (GERD), underlying NCCP. Musculoskeletal chest pain was investigated in three studies (11%), and psychiatric conditions in five studies (18%). Study quality was good in 15 studies (54%) and moderate in 13 (46%; Appendix 4). No study had to be excluded because of poor study quality.

###### 

Baseline characteristic of the studies

  **Author**                                                                                                           **Study design**                                                                                                            **Recruitment**                                                                                                                                                                                                                                                                                                                                            **Inclusion criteria**                                                                                                                                                                                                                                                                                                                                               **Exclusion criteria**                                                                                                                                                                                                                                                                                            **n all (n female), subgroups**                                                                             **Age, mean (SD)**                                                   **Disease duration**
  -------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------------
  Symptoms suggesting gastroesophageal reflux (GERD)-related non-cardiac chest pain (NCCP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Kim *et al*., 2007 \[[@B24]\]                                                                                        Cross-sectional, funding NR                                                                                                 Inpatients with NCCP, referred by a cardiologist after negative cardiac evaluation. Tertiary care, Seoul, Korea.                                                                                                                                                                                                                                           NCCP was defined when patients were admitted for chest pain to the coronary unit for ≥1 episode of unexplained chest pain/week for ≥3 months. Cardiac chest pain was ruled out by electrocardiogram (ECG), normal enzymes, negative treadmill exercise testing, normal or insignificant ECG changes after intravenous ergonovine injection in coronary angiograms.   Severe liver, lung, renal or hematological disorders. History of peptic ulcer or gastrointestinal (GI) surgery, connective tissue disorder and chest pain originating in a musculoskeletal disorder.                                                                                                              58 (female 37), NCCP with GERD symptoms (sy) 24, NCCP without GERD sy 34                                    54.6 (10.4)                                                          17% \<6 months, 17% 6 to 12 months, 51% 1 to 5 years, 16% \>5 years
  Hong *et al*., 2005 \[[@B25]\]                                                                                       Retrospective data analysis, funding NR                                                                                     Patients with a clinical suspicion of esophageal motility abnormalities and pathological acid exposure within 1 month were included in this analysis. Tertiary care, Seoul, Korea.                                                                                                                                                                         Patients with suspicion of esophageal motility abnormalities and pathological acid exposure. NCCP was defined as recurrent angina-like or substernal chest pain believed to be unrelated to the heart, after comprehensive evaluation by the cardiologist.                                                                                                           Obstructive lesions, previous esophageal balloon dilatation, botulism toxin injection, or anti-reflux surgery. No complaints associated with symptoms centered on the esophagus. Connective tissue diseases.                                                                                                      462 (female 269), dysphagia 53, NCCP 186, GERD sy 117                                                       47.6 (10.9)                                                          NR
  Netzer *et al*., 1999 \[[@B26]\]                                                                                     Retrospective data analysis, funding NR                                                                                     First-time referrals to esophageal function testing laboratory. Tertiary care, Bern, Switzerland.                                                                                                                                                                                                                                                          First-time referrals to esophageal function testing laboratory. NCCP group included all patients referred for GI testing because of NCCP. Additional information was obtained by contacting the general practitioner (GP) and interviews.                                                                                                                            NR                                                                                                                                                                                                                                                                                                                303 (female 145), GERD 143, dysphagia 56, NCCP 45                                                           50 (15)                                                              NR
  Mousavi *et al*., 2007 \[[@B27]\]                                                                                    Prospective observational, funding NR                                                                                       Outpatient referral by cardiologist after non-invasive diagnostic evaluation and exclusion of a cardiac or other source. Semnan, Iran.                                                                                                                                                                                                                     Patients with NCCP referred to the gastrointestinal clinic. NCCP was diagnosed when chest pain was believed to be unrelated to the heart after an evaluation by a cardiologist including non-invasive testing and no apparent other diagnosis was present.                                                                                                           Non-steroidal anti-inflammatory drug (NSAID) use, peptic stricture, duodenal/gastric ulcer. History of upper GI surgery, scleroderma, diabetes mellitus, neuropathy, myopathy or functional bowel disorders, any condition that may affect lower esophageal sphincter pressure or decrease acid clearance time.   78 (female 37), NCCP with GERD sy. 35, NCCP without GERD 43                                                 50.4 (2.3)                                                           3 to 30 days (mean 9.3 ± 4.2 days)
  Singh *et al*., 1993 \[[@B28]\]                                                                                      Retrospective data analysis, funding NR                                                                                     All consecutive outpatients referred to Esophageal Laboratory for evaluation of upper gastrointestinal complaints. Alabama, USA.                                                                                                                                                                                                                           61 patients had NCCP and were analyzed in comparison to reflux patients for findings in upper gastrointestinal endoscopy and ambulatory 24 h pH monitoring                                                                                                                                                                                                           NR                                                                                                                                                                                                                                                                                                                153 (female 40)                                                                                             NR                                                                   NR
  Ho *et al*., 1998 \[[@B29]\]                                                                                         Cross-sectional, research grant, National University of Singapore                                                           Outpatient referral for NCCP to the gastroenterology service. Tertiary care, Singapore.                                                                                                                                                                                                                                                                    Recurrent NCCP ≥3 months. Normal cardiac evaluation (non-obstructed coronary arteries (\<50% diameter narrowing), dobutamine stress echocardiography, exercise ECG). Cardiologist evaluation not cardiac.                                                                                                                                                            No history of esophageal disorder or esophageal surgery                                                                                                                                                                                                                                                           61 (NR)                                                                                                     NR                                                                   ≥3 months
  Lam *et al*., 1992 \[[@B30]\]                                                                                        Cross-sectional, funding NR                                                                                                 Patients referred to the gastroenterologist after being released from a cardiac care unit (CCU) where they were admitted with suspected myocardial infarction but negative cardiac evaluation. Secondary care, Haarlem, The Netherlands. Patients were eligible for the study when a cardiologist determined the chest pain to be of non-cardiac origin.   Episode of acute, prolonged retrosternal chest pain. Cardiac chest pain was ruled out when no abnormalities on admission ECG, negative results on heart enzyme tests, negative exercise test. Further cardiac testing (coronary angiography) was only performed when considered necessary by the cardiologist.                                                       Age \>80 years, ECG ischemic alterations on the admission, arrhythmias, or signs of congestive heart failure                                                                                                                                                                                                      41 (female 41)                                                                                              61.4 (range 40 to 75)                                                Acute episode of chest pain
  Studies investigating the efficacy and diagnostic value of proton pump inhibitor (PPI) trials in GERD-related NCCP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Dickman *et al*., 2005 \[[@B31]\]                                                                                    Randomized, controlled trial (RCT), double-blind, crossover, Janssen Pharmaceutica und Eisai Inc.                           Outpatient referral by a cardiologist after negative cardiac evaluation. Tertiary care, Arizona, USA.                                                                                                                                                                                                                                                      NCCP ≥3 episodes/week (angina-like) for ≥3 months. Normal/insignificant findings coronary angiogram, or insufficient evidence for ischemic heart disease (IHD) in non-invasive tests.                                                                                                                                                                                Severe comorbidity, previous empirical anti-reflux regimen, history of peptic ulcer disease or gastrointestinal surgery                                                                                                                                                                                           35 (female 12), GERD + 16 (45.7%), GERD- 19 (54.3%)                                                         55.6 (10.10)                                                         ≥3 months
  Bautista *et al*. 2004 \[[@B32]\]                                                                                    RCT, double-blind, crossover, TAP Pharmaceuticals                                                                           Outpatient referral by a cardiologist after negative cardiac evaluation. Tertiary care, Arizona, USA.                                                                                                                                                                                                                                                      NCCP ≥3 episodes (angina-like) for ≥3 months. Normal/insignificant findings coronary angiogram, or insufficient evidence for IHD in non-invasive tests.                                                                                                                                                                                                              Severe comorbidity, previous empirical anti-reflux regimen, history of peptic ulcer disease or gastrointestinal surgery                                                                                                                                                                                           40 (female 9), placebo 40, GERD + 18, GERD- 22                                                              54.4 (2.78)                                                          ≥3 months
  Fass *et al*. 1998 \[[@B33]\]                                                                                        RCT, double-blind, crossover, Astra-Merck research grant                                                                    Outpatient referral by a cardiologist after negative cardiac evaluation. Tertiary care, Arizona, USA.                                                                                                                                                                                                                                                      NCCP ≥3 episodes (angina-like) for ≥3 months. Normal/insignificant findings coronary angiogram, or insufficient evidence for IHD in non-invasive tests.                                                                                                                                                                                                              Previous empirical anti-reflux regimen, history of peptic ulcer disease or gastrointestinal surgery                                                                                                                                                                                                               37 (female 1), GERD + 23, GERD- 14                                                                          58.2 (2.3)                                                           ≥3 months
  Pandak *et al*., 2002 \[[@B34]\]                                                                                     RCT, double-blind, crossover, Astra Zeneca                                                                                  Patients presented with recurrent chest pain, whose chest pain was determined by cardiologist to be of non-cardiac origin with the aid of methoxyisobutylisonitrile (MIBI) testing. Tertiary care, Arizona, USA.                                                                                                                                           Unexplained recurrent chest pain determined to be of non-cardiac origin by a cardiologist and had negative results on MIBI testing                                                                                                                                                                                                                                   Previous empirical anti-reflux regimen, gastric or duodenal ulcer, prior gastric surgery, abnormalities on physical exam or chest x-ray that would explain the chest pain                                                                                                                                         42 (female 24), GERD + 20, GERD- 18                                                                         Range 22 to 77                                                       ≥6 months
  Kim *et al*., 2009 \[[@B35]\]                                                                                        Prospective observational, Janssen Pharmaceuticals                                                                          Inpatients referred after negative cardiac examination by cardiologists to gastroenterology. Tertiary care, Seoul, Korea.                                                                                                                                                                                                                                  NCCP was defined when patients were admitted for chest pain to the coronary unit for ≥1 episode of unexplained chest pain/week for ≥3 months. Cardiac chest pain was ruled out by ECG, normal enzymes, negative treadmill exercise testing, normal or insignificant ECG changes after intravenous ergonovine injection in coronary angiograms.                       Severe comorbidity, history of peptic ulcer disease or gastrointestinal surgery, history of connective tissue disorder and chest pain originating from musculoskeletal disorder                                                                                                                                   42 (female 17), GERD + 16, GERD- 26                                                                         53.9 (12.8)                                                          ≥3 months: n = 12 3 to 12 months; n = 23 1 to 5 years; n = 7 \>5 years
  Xia *et al*., 2003 \[[@B36]\]                                                                                        RCT, single blind, Simon KY Lee Gastroenterology Research Fund                                                              Referred by a cardiologist after negative cardiac evaluation. Tertiary care, Hong Kong, China.                                                                                                                                                                                                                                                             NCCP ≥12 weeks during last 12 months. Normal coronary angiograph, chest pain considered by a cardiologist to be NCCP.                                                                                                                                                                                                                                                Pathologic endoscopic finding, previous anti-reflux regimen, apparent heartburn, acid reflux, dysphagia and dyspepsia                                                                                                                                                                                             68 (female 42), placebo 32, lansoprazole 36                                                                 58.2 (10.0)                                                          ≥12 weeks
  Kushnir *et al*., 2010 \[[@B37]\]                                                                                    Retrospective data analysis, Mentors in Medicine, Washington University, St Louis, MO, USA                                  Outpatients referred for ambulatory pH monitoring for the evaluation of unexplained chest pain. Tertiary care, Missouri, USA.                                                                                                                                                                                                                              Unexplained chest pain. Cardiac causes were excluded in all instances before referral.                                                                                                                                                                                                                                                                               Anti-reflux surgery in the past, chest pain was not the dominant symptom, pH manometry data incomplete                                                                                                                                                                                                            98 (female 75)                                                                                              51.8 (1.1)                                                           7.4 ± 4.1 years
  Lacima *et al*. 2003 \[[@B38]\]                                                                                      Cross-sectional, funding NR                                                                                                 Referred by a cardiologist after negative cardiac evaluation. Barcelona, Spain.                                                                                                                                                                                                                                                                            Normal ECG, cardiac enzymes, treadmill exercise testing, coronary angiography and epicardial coronary arteries or with \<25% narrowing, no ECG changes after intravenous ergonovine injection                                                                                                                                                                        Previous anti-reflux regimen, calcium channel blockers, beta blockers and/or nitrates were withdrawn at least 7 days before the study                                                                                                                                                                             120 (female 62), patients 90, volunteers 30                                                                 57 (27 to 82)                                                        NR
  Studies investigating the value of provocation tests for the diagnosis of GERD-related NCCP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Cooke *et al*., 1994 \[[@B39]\]                                                                                      Cross-sectional, funding NR                                                                                                 Patients in whom coronary angiography was performed for the diagnosis of new chest pain. Secondary care, London, UK.                                                                                                                                                                                                                                       New chest pain and normal coronary anatomy with exertional pain as principal complaint                                                                                                                                                                                                                                                                               Mitral valve prolapse, left ventricular hypertrophy, previous myocardial infarction, abnormalities of resting wall motion on echocardiography, pain at rest only, unable to exercise. Previous anti-reflux regimen, previous gastroenterologist assessment.                                                       66 (female 34), non-cardiovascular disease (CVD) 50, CVD 16 (controls)                                      53 (non-CVD), CVD 58, range 32 to 72                                 3.4 years
  Bovero *et al*., 1993 \[[@B40]\]                                                                                     Cross-sectional, funding NR                                                                                                 Patients investigated for chest pain. Secondary care, Genova, Italy.                                                                                                                                                                                                                                                                                       Chest pain, no coronaroactive drugs for ≥5 days. No anti-reflux regimen ≥3 days.                                                                                                                                                                                                                                                                                     Chest pain of organic and/or functional cardiologic origin (evaluated by: ECG, two ergometry tests, dynamic ECG, thallium myocardial scintigraphy under physical stress or echodypiridamole test, ergonovine or methyl-ergometrine test, angiography)                                                             67 (female 43), pain at rest 46, exertional pain 21                                                         53 (range 34 to 76)                                                  NR
  Romand *et al*., 1999 \[[@B41]\]                                                                                     Cross-sectional, funding NR                                                                                                 Referred after negative cardiac evaluation. Secondary care, Lyon, France.                                                                                                                                                                                                                                                                                  Normal coronary anatomy, normal ECG, negative treadmill exercise                                                                                                                                                                                                                                                                                                     Cardiologic origin of symptoms, history of upper gastrointestinal surgery, duodenal or gastric ulcer, peptic stricture or stricture by a tumor                                                                                                                                                                    43 (female 19)                                                                                              56 (range 31 to 78)                                                  n = 25 \<1 year; n = 7 1 to 5 years; n = 11 \>5 years
  Abrahao *et al*., 2005 \[[@B42]\]                                                                                    Cross-sectional, funding NR                                                                                                 Referred by a cardiologist after negative cardiac evaluation. Tertiary care, Rio de Janeiro, Brazil.                                                                                                                                                                                                                                                       ≥1 episode of NCCP/week, normal coronary angiogram or with \<30% narrowing                                                                                                                                                                                                                                                                                           Chronic obstructive lung disease, asthma, cardiac arrhythmia, cardiomyopathy, valvular heart disease                                                                                                                                                                                                              40 (female 32)                                                                                              54.7 (8.4)                                                           Mean 24 months (range 1 to 360 months)
  Ho *et al*., 1998 \[[@B29]\]                                                                                         Cross-sectional, research grant from the National University of Singapore                                                   Referred for NCCP to the gastroenterology service, Singapore                                                                                                                                                                                                                                                                                               Recurrent chest pain of ≥3 months; cardiologists evaluation normal and symptoms not cardiac (non-obstructed coronary arteries (\<50% luminal narrowing), dobutamine stress echocardiography, exercise ECG)                                                                                                                                                           No history of proven esophageal disorder or esophageal surgery                                                                                                                                                                                                                                                    80 (female 38)                                                                                              48 (range 21 to 75)                                                  ≥3 months
  Eosinophilic esophagitis-related NCCP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Achem *et al*., 2011 \[[@B43]\]                                                                                      Retrospective data analysis, funding NR                                                                                     Referred for endoscopic evaluation of NCCP, who had esophageal biopsies for suspected eosinophilic esophagitis. Secondary care, Florida, USA.                                                                                                                                                                                                              Chest pain suspected of being esophageal origin after negative cardiac evaluation (either by non-invasive stress testing or coronary angiography)                                                                                                                                                                                                                    Dysphagia (if this was the main reason for endoscopy). Anticoagulant use.                                                                                                                                                                                                                                         171 (female 104), 24 (female 7) eosinophilia, 147 (female 97) normal histology                              59 (24 to 86) normal histology, 55 (21 to 81) eosinophilia           NR
  Musculoskeletal NCCP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Stochkendahl *et al*., 2012 \[[@B44]\]                                                                               Cross-sectional, Foundation Chiropractic Research and Postgraduate Education, Government                                    Patients discharged form an emergency cardiology department. Tertiary care, Odense, Denmark.                                                                                                                                                                                                                                                               Acute (\<7 days) chest pain primary complaint. Pain in the thorax and/or neck. Understand Danish. Age 18 to 75 years, resident of the Funen County.                                                                                                                                                                                                                  Cardiovascular disease, previous percutaneous coronary intervention or coronary artery bypass graft: other definite cause, inflammatory joint disease, insulin dependent diabetes, fibromyalgia, malignant disease, apoplexy, dementia or unable to cooperate, major osseous anomaly, osteoporosis, pregnancy     302 (female 132)                                                                                            52.5 (11.0)                                                          Acute episode, \<7 days before admission
  Bosner *et al*. 2010 \[[@B45]\]                                                                                      Cross-sectional with 6 months follow-up, federal Ministry of Education and Research grant                                   Consecutive recruitment of all patients presenting to chest pain in a GP clinic. An independent interdisciplinary reference panel decided about the etiology of chest pain.                                                                                                                                                                                Age \>35 years, pain (acute or chronic) localized between clavicles and lower costal margins and anterior to the posterior axillary lines                                                                                                                                                                                                                            Patients whose chest pain had been investigated already and/or who came for follow-up for previously diagnosed chest pain were excluded                                                                                                                                                                           1,212 (female 678), chest wall symptom (CWS) 565 (female 330)                                               All 59 (35 to 93), CWS 58 (35 to 90)                                 Acute pain 28.4%
  Manchikanti *et al*., 2002 \[[@B46]\]                                                                                Cross-sectional, no funding                                                                                                 Chronic thoracic pain, managed by one physician and undergoing diagnostic medial branch blocks. Private pain practice, USA.                                                                                                                                                                                                                                Pain for ≥6 months. Failure of conservative management with physical therapy, chiropractic management and drug therapy. Age 18 to 90 years.                                                                                                                                                                                                                          No radicular pattern of pain, no disc herniation on MRI                                                                                                                                                                                                                                                           46 (female 31)                                                                                              46 (2.2)                                                             ≥6 months, mean 86 (SD 17.2) months
  NCCP related to psychiatric diseases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Kuijpers *et al*., 2003 \[[@B47]\]                                                                                   Cross-sectional, funding NR                                                                                                 Discharged from the hospitals first-heart-aid service with a diagnosis of NCCP received an envelope                                                                                                                                                                                                                                                        Chest pain or palpitation presenting to first-heart-aid service, received no cardiac explanation                                                                                                                                                                                                                                                                     Dementia, live ≥50 km from the hospital. Do not speak Dutch.                                                                                                                                                                                                                                                      344 (female 151), Hospital Anxiety Depression Scale (HADS) ≥8: 266 (female 123); HADS \<8: 78 (female 28)   HADS ≥8: 55.81 (13.03); HADS \<8: 60.55 (10.84)                      NR
  Demiryoguran *et al*., 2006 \[[@B48]\]                                                                               Cross-sectional, funding NR                                                                                                 Patients admitted to the ER and discharged with a diagnosis of NCCP. Ismir, Turkey.                                                                                                                                                                                                                                                                        Cardiac chest pain ruled out. Normal ECGs and low or stable levels of cardiac markers.                                                                                                                                                                                                                                                                               Unstable vital signs, uncooperative and disoriented patients. Established diagnoses. Documented coronary artery disease, history of trauma to chest wall, back or abdomen within the previous week.                                                                                                               157 (female 89), HADS \<10: 108 (female 55), HADS \>10: 49 (female 34)                                      41.6 (11.7)                                                          NR
  Foldes-Busque *et al*., 2011 \[[@B49]\]                                                                              Cross-sectional, Groupe interuniversitaire de recherche sur les urgences (GIRU) and Fonds de Recherche en Santé du Québec   Emergency department (ED), Monday to Friday between 8 AM and 4 PM. Tertiary care, Quebec, Canada.                                                                                                                                                                                                                                                          Low-risk unexplained chest pain, ≥18 years old. English or French speaking, normal serial ECG, normal cardiac enzymes.                                                                                                                                                                                                                                               Explained chest pain (for example, ischemic, cause identifiable by radiography). Medical condition that could invalidate the interview (for example, psychosis, intoxication, or cognitive deficit), any unstable condition, or any trauma.                                                                       507 (NR), derivation sample 201 (female 101); validation sample 306 (female 173)                            Derivation condition 54.2 (13.9), validation condition 53.3 (14.4)   NR
  Fleet *et al*. 1997 \[[@B50]\]                                                                                       Cross-sectional, Fonds de Recherché en Santé Québec                                                                         Consecutive patients presenting to ambulatory walk in ED, patients with or without IHD, Québec, Canada                                                                                                                                                                                                                                                     Complaint of chest pain, understand French, able to complete evaluation in the ED                                                                                                                                                                                                                                                                                    Cognitive impairment, psychotic state                                                                                                                                                                                                                                                                             Derivation sample 180 (female 63), validation sample 212                                                    Development 57.6 (12.6), validation 56 (12.2)                        NR
  Katerndahl *et al*., 1997 \[[@B51]\]                                                                                 Cross-sectional, public health and service Establishment of Departments of Family Practice                                  Presented to the GP with a chief compliant of new-onset chest pain. Primary care, Texas, USA.                                                                                                                                                                                                                                                              Adults 18 years and older, new-onset chest pain, only one complaint (chest pain) as well as those with several symptoms that included chest pain                                                                                                                                                                                                                     Previous investigation for chest pain at the practice                                                                                                                                                                                                                                                             51 (NR)                                                                                                     42.6 (14.6)                                                          New onset

*NR* not reported.

Accuracy of symptoms for the diagnosis of GERD
----------------------------------------------

Table [2](#T2){ref-type="table"} summarizes the diagnostic accuracy of the diagnostic tests relevant for clinical practice. A comprehensive overview of all evaluated diagnostic tests is provided in Appendix 5. For diagnosis of GERD, the most common reference tests (endoscopy and/or 24-h pH-metry) are reported.

###### 

Summary of diagnostic accuracy of tests used in non-cardiac chest pain

  **Author, year**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---- ------- ------
  Symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Kim *et al*. \[[@B24]\]                                                                                                                                                                                                                                                                                                                                               NCCP with atypical GERD symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                      Endoscopy (LA classification) and/or 24 h pH-metry (\>4%, pH \<4                                                                                                            24   0.49    2.71
  Kim *et al*. \[[@B24]\]                                                                                                                                                                                                                                                                                                                                               NCCP with typical GERD symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                       Same                                                                                                                                                                        67   2.75    0.42
  Mousavi *et al*. \[[@B27]\]                                                                                                                                                                                                                                                                                                                                           NCCP with typical GERD symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                       GERD if two tests positive: endoscopy (Hentzel-Dent), Bernstein test, omeprazole trial                                                                                      45   2.70    0.78
  Mousavi *et al*. \[[@B27]\]                                                                                                                                                                                                                                                                                                                                           NCCP relieved by antacid                                                                                                                                                                                                                                                                                                                                                                                                                                                              Same                                                                                                                                                                        45   0.51    3.51
  Mousavi *et al*. \[[@B27]\]                                                                                                                                                                                                                                                                                                                                           NCCP and heartburn in past history                                                                                                                                                                                                                                                                                                                                                                                                                                                    Same                                                                                                                                                                        45   2.15    0.74
  Mousavi *et al*. \[[@B27]\]                                                                                                                                                                                                                                                                                                                                           NCCP and regurgitation in past history                                                                                                                                                                                                                                                                                                                                                                                                                                                Same                                                                                                                                                                        45   2.98    0.61
  Hong *et al*. \[[@B25]\]                                                                                                                                                                                                                                                                                                                                              NCCP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Manometry (Specler 2001 criteria) and/or 24 h pH-metry (\>4% pH \<4)                                                                                                        43   0.83    1.13
  Hong *et al*. \[[@B25]\]                                                                                                                                                                                                                                                                                                                                              Control: dysphagia                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Same                                                                                                                                                                        45   1.27    0.97
  Hong *et al*. \[[@B25]\]                                                                                                                                                                                                                                                                                                                                              Control: GERD-typical symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                        Same                                                                                                                                                                        44   1.26    0.93
  Netzer *et al*. \[[@B26]\]                                                                                                                                                                                                                                                                                                                                            NCCP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Manometry and/or 24 h pH-metry (\>10.5% pH \<4)                                                                                                                             84   0.43    1.23
  Netzer *et al*. \[[@B26]\]                                                                                                                                                                                                                                                                                                                                            Control: GERD-typical symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                        Same                                                                                                                                                                        84   1.53    0.74
  Netzer *et al*. \[[@B26]\]                                                                                                                                                                                                                                                                                                                                            Control: dysphagia                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Same                                                                                                                                                                        84   1.16    0.97
  Proton pump inhibitor (PPI) trial                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Dickman *et al*. \[[@B31]\]                                                                                                                                                                                                                                                                                                                                           Rabeprazole 20 mg twice a day for 1 week SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                     Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                        46   7.13    0.28
  Dickman *et al*. \[[@B31]\]                                                                                                                                                                                                                                                                                                                                           Placebo for 1 week                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Same                                                                                                                                                                        46   0.89    1.03
  Bautista *et al*. \[[@B32]\]                                                                                                                                                                                                                                                                                                                                          Lansoprazole 60 mg AM, 30 mg PM for 1 week SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                   Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                        45   8.56    0.24
  Bautista *et al*. \[[@B32]\]                                                                                                                                                                                                                                                                                                                                          Lansoprazole 60 mg AM, 30 mg PM for 1 week SIS ≥65%                                                                                                                                                                                                                                                                                                                                                                                                                                   Same                                                                                                                                                                        45   18.33   0.17
  Bautista *et al*. \[[@B32]\]                                                                                                                                                                                                                                                                                                                                          Placebo for 1 week                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Same                                                                                                                                                                        45   0.61    1.22
  Fass *et al*. \[[@B33]\]                                                                                                                                                                                                                                                                                                                                              Omeprazole 40 mg AM, 20 mg PM for 1 week SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                     Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                        62   5.48    0.25
  Fass *et al*. \[[@B33]\]                                                                                                                                                                                                                                                                                                                                              Placebo for 1 week                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Same                                                                                                                                                                        62   3.04    0.84
  Pandak *et al*. \[[@B34]\]                                                                                                                                                                                                                                                                                                                                            Omeprazole 40 mg twice a day for 2 weeks SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                     Endoscopy and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                                              53   2.70    0.15
  Pandak *et al*. \[[@B34]\]                                                                                                                                                                                                                                                                                                                                            Placebo for 2 weeks SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                                          Same                                                                                                                                                                        53   0.30    1.14
  Kim *et al*. \[[@B35]\]                                                                                                                                                                                                                                                                                                                                               NCCP rabeprazole for 1 week SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                                  Endoscopy (LA classification) and/or 24 h pH-metry (\>4.0 pH \<4)                                                                                                           38   2.17    0.65
  Kim *et al*. \[[@B35]\]                                                                                                                                                                                                                                                                                                                                               NCCP rabeprazole for 2 weeks SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                                 Same                                                                                                                                                                        38   3.02    0.26
  Xia *et al*. \[[@B36]\]                                                                                                                                                                                                                                                                                                                                               Lansoprazole 30 mg once a day for 4 weeks SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                    24 h pH-metry (De Meester pH \<4, 7.5 s)                                                                                                                                    33   2.75    0.13
  Xia *et al*. \[[@B36]\]                                                                                                                                                                                                                                                                                                                                               Placebo for 4 weeks SIS ≥50%                                                                                                                                                                                                                                                                                                                                                                                                                                                          Same                                                                                                                                                                        38   0.95    1.03
  Kushnir *et al*. \[[@B37]\]                                                                                                                                                                                                                                                                                                                                           High-degree response on PPI (not specified)                                                                                                                                                                                                                                                                                                                                                                                                                                           24 pH-metry (≥4%, pH \<4)                                                                                                                                                   53   1.97    0.38
  Provocation test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Cooke *et al*. \[[@B39]\]                                                                                                                                                                                                                                                                                                                                             NCCP during exertional pH-metry                                                                                                                                                                                                                                                                                                                                                                                                                                                       24 h pH-metry (5.5% pH \<4 for 10 s)                                                                                                                                        38   14.40   0.79
  Cooke *et al*. \[[@B39]\]                                                                                                                                                                                                                                                                                                                                             Control group: CVD with angina: exertional pH-metry                                                                                                                                                                                                                                                                                                                                                                                                                                   Same                                                                                                                                                                        19   4.33    0.72
  Bovero *et al*. \[[@B40]\]                                                                                                                                                                                                                                                                                                                                            NCCP with normal ECG during exertional pH-metry                                                                                                                                                                                                                                                                                                                                                                                                                                       24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                         69   7.76    0.66
  Bovero *et al*. \[[@B40]\]                                                                                                                                                                                                                                                                                                                                            NCCP at rest: NCCP with normal ECG during exertional pH-metry                                                                                                                                                                                                                                                                                                                                                                                                                         Same                                                                                                                                                                        74   3.88    0.74
  Bovero *et al*. \[[@B40]\]                                                                                                                                                                                                                                                                                                                                            NCCP exertion/mixed: NCCP with normal ECG during exertional pH-metry                                                                                                                                                                                                                                                                                                                                                                                                                  Same                                                                                                                                                                        57   10.00   0.50
  Romand *et al*. \[[@B41]\]                                                                                                                                                                                                                                                                                                                                            NCCP: pH \<4 for 10 s during exertional pH-metry                                                                                                                                                                                                                                                                                                                                                                                                                                      24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                         23   1.65    0.52
  Abrahao *et al*. \[[@B42]\]                                                                                                                                                                                                                                                                                                                                           NCCP reproducible during balloon distension                                                                                                                                                                                                                                                                                                                                                                                                                                           Endoscopy (Savary-Miller) and/or manometry and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                              88   2.00    0.75
  Abrahao *et al*. \[[@B42]\]                                                                                                                                                                                                                                                                                                                                           NCCP reproducible during Tensilon test                                                                                                                                                                                                                                                                                                                                                                                                                                                Same                                                                                                                                                                        88   0.43    1.38
  Abrahao *et al*. \[[@B42]\]                                                                                                                                                                                                                                                                                                                                           NCCP reproducible during Bernstein test                                                                                                                                                                                                                                                                                                                                                                                                                                               Same                                                                                                                                                                        88   1.29    0.93
  Abrahao *et al*. \[[@B42]\]                                                                                                                                                                                                                                                                                                                                           Tensilon and Bernstein Test and balloon distension (+ if 1 test +)                                                                                                                                                                                                                                                                                                                                                                                                                    Same                                                                                                                                                                        88   0.95    1.07
  Ho *et al*. \[[@B29]\]                                                                                                                                                                                                                                                                                                                                                NCCP reproducible during Bernstein test                                                                                                                                                                                                                                                                                                                                                                                                                                               24 h pH-metry (\>4% pH \<4, 4 s)                                                                                                                                            23   0.75    1.06
  Musculoskeletal disorders                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      ≥3 of 5 palpation findings: (1) sitting motion of end-play restriction in lateral flexion and rotation segment C4 to C7 and Th1 to Th8. (2) Prone motion joint-play restriction segment Th1 to Th8. (3) Prone evaluation paraspinal tenderness segment Th1 to Th8. (4) Supine manual palpation muscular tenderness of 14 points anterior chest wall. 5) Supine evaluation of tenderness of the costosternal junctions of costa 2 to 6 and xiphoid process                             Diagnosis using a standardized examination protocol:                                                                                                                        37   1.52    0.03
  \(1\) A semistructured interview: pain characteristics, lung and gastrointestinal symptoms, past medical history, height, weight, cardiovascular risk factors                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  \(2\) A general health examination: blood pressure, pulse, heart and lung stethoscopy, abdominal palpation, neck auscultation, signs of left ventricular failure, neurological examination                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  \(3\) Manual examination of the muscles and joints (neck, thoracic spine and thorax): active range of motion, manual palpation 14 points muscular tenderness of the anterior chest wall and segmental paraspinal muscles, motion palpation for joint-play restriction of the thoracic spine (Th1 to 8), and end play restriction of the cervical and thoracic spine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Chest wall symptom (CWS) score: localized muscle tension, stinging pain, pain reproducible by palpation, absence of cough                                                                                                                                                                                                                                                                                                                                                             Interdisciplinary consensus: cardiologist, GP, research associate (based on reviewed baseline, follow-up data at 6 weeks and 6 months)                                      47   1.82    0.20
  Cut-off test negative 0 to 1 points                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            CWS score: localized muscle tension, stinging pain, pain reproducible by palpation, absence of cough                                                                                                                                                                                                                                                                                                                                                                                  Interdisciplinary consensus                                                                                                                                                 47   3.02    0.47
  Cut-off test negative 0 to 2 points                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Biomechanical dysfunction (part of the standardized examination protocol)^a^                                                                                                                                                                                                                                                                                                                                                                                                          Standardized examination protocol                                                                                                                                           37   1.58    0.00
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Anterior chest wall tenderness                                                                                                                                                                                                                                                                                                                                                                                                                                                        Standardized examination protocol                                                                                                                                           37   1.39    0.06
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Angina pectoris (uncertain or negative)                                                                                                                                                                                                                                                                                                                                                                                                                                               Standardized examination protocol                                                                                                                                           37   1.26    0.12
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Pain worse on movement of torso                                                                                                                                                                                                                                                                                                                                                                                                                                                       Standardized examination protocol                                                                                                                                           37   3.39    0.78
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Pain worse with movement                                                                                                                                                                                                                                                                                                                                                                                                                                                              Interdisciplinary consensus                                                                                                                                                 47   2.13    0.75
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Positive/possible belief in pain origin from muscle/joints                                                                                                                                                                                                                                                                                                                                                                                                                            Standardized examination protocol                                                                                                                                           37   1.17    0.20
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Pain relief on pain medication                                                                                                                                                                                                                                                                                                                                                                                                                                                        Standardized examination protocol                                                                                                                                           37   3.26    0.83
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Pain reproducible by palpation                                                                                                                                                                                                                                                                                                                                                                                                                                                        Interdisciplinary consensus                                                                                                                                                 47   2.08    0.54
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Paraspinal tenderness                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Standardized examination protocol                                                                                                                                           37   1.36    0.48
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Localized muscle tension                                                                                                                                                                                                                                                                                                                                                                                                                                                              Interdisciplinary consensus                                                                                                                                                 47   2.41    0.52
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Chest pain present now                                                                                                                                                                                                                                                                                                                                                                                                                                                                Standardized examination protocol                                                                                                                                           37   1.35    0.46
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Pain now                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Interdisciplinary consensus                                                                                                                                                 47   1.15    0.85
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Pain debut not during a meal                                                                                                                                                                                                                                                                                                                                                                                                                                                          Standardized examination protocol                                                                                                                                           37   1.10    0.23
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Sharp pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Standardized examination protocol                                                                                                                                           37   1.89    0.80
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Stinging pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Interdisciplinary consensus                                                                                                                                                 47   1.87    0.66
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Hard physical exercise at least once a week                                                                                                                                                                                                                                                                                                                                                                                                                                           Standardized examination protocol                                                                                                                                           37   1.19    0.91
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Pain not provoked during a meal                                                                                                                                                                                                                                                                                                                                                                                                                                                       Standardized examination protocol                                                                                                                                           37   1.09    0.25
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Not sudden debut                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Standardized examination protocol                                                                                                                                           37   2.90    0.63
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Pain \>24 h                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Interdisciplinary consensus                                                                                                                                                 47   1.30    0.92
  Stochkendahl *et al*. \[[@B44]\]                                                                                                                                                                                                                                                                                                                                      Age ≤49 years old                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Standardized examination protocol                                                                                                                                           37   2.10    0.56
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Pain mostly at noon time                                                                                                                                                                                                                                                                                                                                                                                                                                                              Interdisciplinary consensus                                                                                                                                                 47   0.50    1.02
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Cough                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Interdisciplinary consensus                                                                                                                                                 47   0.28    1.18
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Known IHD                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Interdisciplinary consensus                                                                                                                                                 47   0.52    1.11
  Bosner *et al*. \[[@B45]\]                                                                                                                                                                                                                                                                                                                                            Pain worse with breathing                                                                                                                                                                                                                                                                                                                                                                                                                                                             Interdisciplinary consensus                                                                                                                                                 47   1.28    0.93
  Psychiatric diseases                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Kuijpers *et al*. \[[@B47]\]                                                                                                                                                                                                                                                                                                                                          Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A score, cut-off ≥8)                                                                                                                                                                                                                                                                                                                                                                                              Diagnosis anxiety disorders (Mini International Neuropsychiatric Interview (gold standard))                                                                                 58   2.03    0.03
  Demiryoguran *et al*. \[[@B48]\]                                                                                                                                                                                                                                                                                                                                      Chills or hot flushes                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                                31   4.85    0.81
  Demiryoguran *et al*. \[[@B48]\]                                                                                                                                                                                                                                                                                                                                      Fear of dying                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                                31   4.04    0.82
  Demiryoguran *et al*. \[[@B48]\]                                                                                                                                                                                                                                                                                                                                      Diaphoresis                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                                31   3.49    0.69
  Demiryoguran *et al*. \[[@B48]\]                                                                                                                                                                                                                                                                                                                                      Light-headedness, dizziness, faintness                                                                                                                                                                                                                                                                                                                                                                                                                                                Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                                31   3.03    0.84
  Demiryoguran *et al*. \[[@B48]\]                                                                                                                                                                                                                                                                                                                                      Palpitation                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                                31   1.54    0.83
  Demiryoguran *et al*. \[[@B48]\]                                                                                                                                                                                                                                                                                                                                      Shortness of breath                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                                31   1.30    0.92
  Demiryoguran *et al*. \[[@B48]\]                                                                                                                                                                                                                                                                                                                                      Nausea or gastric discomfort                                                                                                                                                                                                                                                                                                                                                                                                                                                          Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                                31   1.98    0.90
  Foldes-Busque *et al*. \[[@B49]\]                                                                                                                                                                                                                                                                                                                                     The Panic Screening Score (derivation population); does the patient have a history of anxiety disorders? Please indicate how often this thought occurs when you are nervous: 'I will choke to death'. Did the patient arrive in the ED by ambulance? Please answer the statement by circling the number that best applies to you: 'When I notice my heart beating rapidly, I worry that I might be having a heart attack'. Sum score 22, A total score ≥6 indicates probable panic.   Panic disorder Diagnosis (structured Anxiety Disorders Interview Schedule for *Diagnostic and Statistical Manual of Mental Disorders*, fourth edition (DSM-IV) (ADIS-IV))   42   3.89    0.44
  Foldes-Busque *et al*. \[[@B49]\]                                                                                                                                                                                                                                                                                                                                     The Panic Screening Score (validation population).                                                                                                                                                                                                                                                                                                                                                                                                                                    Panic disorder diagnosis (structured ADIS-IV)                                                                                                                               43   3.44    0.55
  Fleet *et al*. \[[@B50]\]                                                                                                                                                                                                                                                                                                                                             Panic disorder diagnosis: formula including Agoraphobia Cognitions QA, Mobility Inventory for Agoraphobia, Zone 12 Dermatome Pain Map, Sensory McGill Pain QA, Gender, Zone 25 (validation population)                                                                                                                                                                                                                                                                                Panic disorder (ADIS-R structured interview by psychologist)                                                                                                                23   2.60    0.46
  Katerndahl *et al*. \[[@B51]\]                                                                                                                                                                                                                                                                                                                                        GP diagnosis of panic disorder                                                                                                                                                                                                                                                                                                                                                                                                                                                        Panic disorder (structured clinical interview of *Diagnostic and Statistical Manual of Mental Disorders*, based on DSM-III-R)                                               55   0.82    1.02

LR+: \>10; LR-: \<0.1; good: LR + 5 to 10, LR- 0.1 to 0.2; fair: LR + 2 to 5, LR- 0.2 to 0.5; poor: LR + 1 to 2, LR- 0.5 to 1.

^a^Biomechanical dysfunction defined as chest pain presumably caused by mechanical joint and muscle dysfunction related to C4 to Th8 somatic structures of the spine and chest wall established by means of joint-play and/or end-play palpation.

Reference tests are as follows. Endoscopic classification: LA classification: grade A, ≥1 mucosal break ≤5 mm, that does not extend between the tops of two mucosal folds; grade B, ≥1 mucosal break \>5 mm long that does not extend between the tops of two mucosal folds; grade C, ≥1 mucosal break that is continuous between the tops of two or more mucosal folds but which involves \<75% of the circumference; grade D, ≥1 mucosal break which involves at least 75% of the esophageal circumference \[[@B52]\]. Savary-Miller system: grade I, single or isolated erosive lesion(s) affecting only one longitudinal fold; grade II multiple erosive lesions, non-circumferential, affecting more than one longitudinal fold, with or without confluence; grade III, circumferential erosive lesions; grade IV, chronic lesions: ulcer(s), stricture(s) and/or short esophagus. Alone or associated with lesions of grades 1 to 3; grade V, columnar epithelium in continuity with the Z line, non-circular, star-shaped, or circumferential. Alone or associated with lesions of grades 1 to 4 \[[@B53]\]. Hentzel-Dent grades: grade 0, no mucosal abnormalities; grade 1, no macroscopic lesions but erythema, hyperemia, or mucosal friability; grade 2, superficial erosions involving \<10% of mucosal surface of the last 5 cm of esophageal squamous mucosa; grade 3, superficial erosions or ulceration involving 10% to 50% of the mucosal surface of the last 5 cm of esophageal squamous mucosa; grade 4, deep peptide ulceration anywhere in the esophagus or confluent erosion of \>50% of the mucosal surface of the last 5 cm of esophageal squamous mucosa \[[@B54]\]. pH-metry: De Meester criteria: (1) total number of reflux episodes; (2) number of reflux episodes with pH \<4 for more than 5 minutes; (3) duration of the longest episode; (4) percentage total time pH \<4; (5) percentage upright time pH \<4; and (6) percentage recumbent time pH \<4. \[[@B55]\]. Manometry: Spechler criteria is diagnosis of ineffective esophageal motility, nutcracker esophagus, spasm, achalasia based on basal lower esophageal sphincter pressure, relaxation, wave progression, distal wave amplitude \[[@B56]\].

*24-h pH-metry* 24-h pH monitoring, *GERD* gastroesophageal reflux disease, *GP* general practitioner, *IHD* ischemic heart disease, *QA* questionnaire, *Sensory McGill* McGill Pain Questionnaire sensory subscale, *SIS* symptom index score calculated by adding the reported daily severity (mild = 1; moderate = 2; severe = 3; and disabling = 4) multiplied by the reported daily frequency values during each week).

Patients with the main complaint of NCCP were less likely to have GERD (LR + 0.83, 0.43; LR- 1.13, 1.23) compared to patients with the main complaint of dysphagia (LR + 1.27, 1.16; LR- 0.97, 0.97) or GERD typical symptoms without chest pain (LR + 1.26, 1.53; LR- 0.93, 0.74) in two studies \[[@B25],[@B26]\]. Two further studies compared the accuracy of NCCP and typical GERD symptoms (LR + 2.70 \[[@B27]\], 2.75 \[[@B24]\]; LR- 0.42 \[[@B24]\], 0.78 \[[@B27]\]) with NCCP without GERD symptoms (LR + 0.49; LR- 2.71 \[[@B24]\]) or with NCCP and a history of heart burn (LR + 2.15; LR- 0.74 \[[@B27]\]).

Accuracy of response to proton pump inhibitor (PPI) treatment for diagnosis of GERD in NCCP
-------------------------------------------------------------------------------------------

The effect of treatment with PPI was measured by using a symptom intensity score (SIS) at baseline and follow-up. The SIS was calculated by adding the reported daily severity (mild = 1; moderate = 2; severe = 3; and disabling = 4) multiplied by the reported daily frequency values obtained during each week of symptom recording.

Table [2](#T2){ref-type="table"} summarizes the results. Three studies compared the treatment response after high doses of PPI (rabeprazole \[[@B31]\], lansoprazole \[[@B32]\], omeprazole \[[@B33]\]) for 1 week to placebo. A reduction of the SIS score of ≥50% was associated with a good LR + and a fair LR- (LR + 5.48 \[[@B33]\], 7.13 \[[@B31]\], 8.56 \[[@B32]\]; LR- 0.24 \[[@B32]\], 0.25 \[[@B33]\], 0.28 \[[@B31]\]) for the presence or absence of GERD. The likelihood ratios in the placebo groups with a reduction of the SIS score of ≥50% were: LR + 0.89 \[[@B31]\], 0.61 \[[@B32]\], 3.04 \[[@B33]\]; LR- 1.03 \[[@B31]\], 1.22 \[[@B32]\], 0.84 \[[@B33]\]. A reduction of the SIS score of ≥65% resulted in a very good LR + (18.33), and a good LR- (0.17) \[[@B32]\]. A treatment duration of 4 weeks (lasoprazole) resulted in a better LR- (LR + 2.75; LR- 0.13) \[[@B36]\] when compared to 2 weeks (omeprazole \[[@B34]\], LR + 2.7; LR- 0.15).

For joint meta-analysis only studies were considered with similar study design. Therefore, the active treatment arms of six studies were available for further analysis \[[@B31]-[@B36]\]. The model could be extended to include study-specific covariates such as the percentage of female patients or mean age to reduce unexplained heterogeneity on study level. However, due to the small number of studies available for pooling we refrained from including covariates. Figure [2](#F2){ref-type="fig"} shows the summary receiver operating characteristic (ROC) curve. Considering the GERD prevalence and the fact that no perfect reference test is available for GERD (sensitivity of the 24-h pH-metry in endoscopy-negative patients \<71% \[[@B57]\]), the posterior mean sensitivity of what was 0.89 (95% credible interval, 0.28 to 1). The posterior mean of the specificity was 0.88 (95% credible interval, 0.26 to 1), respectively.

![Summary receiver operating characteristic (ROC) curve of proton pump inhibitor (PPI) studies.](1741-7015-11-239-2){#F2}

Accuracy of provocation tests for GERD diagnosis
------------------------------------------------

Using a treadmill test during the 24-h pH-metry (reference test) showed highest LR + for GERD when chest pain was provoked by exercise (LR + 14.4; LR- 0.79 \[[@B39]\]). In all patients who underwent treadmill test, a high number of false negative test results during the treadmill test were observed.

For joint meta-analysis only studies were considered with similar study design, again. Five patient groups from four original studies were included in the analysis \[[@B38]-[@B41]\]. Figure [3](#F3){ref-type="fig"} shows the summary ROC curve. Considering the prevalence and imperfect nature of the reference test, posterior mean sensitivity and specificity were 0.53 (95% credible interval, 0.02 to 1) and 0.93 (95% credible interval, 0.25 to 1), respectively. For all provocation tests (Tensilon test, Bernstein test, or balloon distension test) high numbers of false negative results were found \[[@B29],[@B42]\].

![Summary receiver operating characteristic (ROC) for treadmill test during 24 h pH-metry.](1741-7015-11-239-3){#F3}

Accuracy of patient characteristics for eosinophilic esophagitis diagnosis
--------------------------------------------------------------------------

Eosinophilic esophagitis is a rare but important differential diagnosis for NCCP. In a retrospective analysis the likelihood for histologically proven eosinophilic esophagitis (reference test) was fair when current GERD symptoms were present (LR + 2.36, LR- 0.71 (poor)). Male gender or the presence of typical endoscopic findings for eosinophilic esophagitis were associated with a poor LR + (1.78) but a very good LR- (0.09) No information was available about eosinophilia that responds to PPI treatment compared to eosinophilic esophagitis.

Accuracy of clinical signs for musculoskeletal chest pain diagnosis
-------------------------------------------------------------------

In one study in a cardiology emergency department specific clinical signs or symptoms compared to a standardized examination protocol showed either fair LR + and poor LR- (for example, pain worse with movement of the torso, pain relief on pain medication, no sudden pain start, age ≤49 years) or a poor LR + and a very good LR- (for example, anterior chest wall tenderness, biomechanical dysfunction) \[[@B44]\]. A score of 3 or more points in a sum score (1 point for each of five palpation findings: restriction in C4 to 7/Th1 to Th8 when sitting; prone restriction Th1 to 8; paraspinal tenderness; anterior chest wall tenderness; costosternal junction tenderness) showed an LR + of 1.52 and very good LR- of 0.03. A score of 1 or more points in a sum score for the diagnosis of a chest wall syndrome (CWS) in the GP setting (1 point for each positive finding: localized muscle tension; stinging pain; pain reproducible by palpation; absence of cough) showed a LR + of 1.82 and LR- of 0.20 \[[@B45]\]. A score of 2 or more points in the sum score showed a LR + of 3.02 and LR- of 0.47.

Accuracy of patient characteristics for psychiatric disease diagnosis
---------------------------------------------------------------------

For the diagnosis of an anxiety disorder the anxiety subscale of the Hospital Anxiety and Depression Score (HADS-A, cut-off ≥8) compared to a neuropsychiatric interview (reference test) showed a very good LR- (0.03) and a fair LR + (2.03). In further studies the HADS-A was used as reference test for the diagnosis of anxiety disorder. Specific symptoms showed a fair LR + and a poor LR-: fear of dying (LR + 4.04; LR- 0.82); light-headedness, dizziness, or faintness (LR + 3.03; LR- 0.84); diaphoresis (LR + 3.49; LR- 0.69); and chills or hot flushes (LR + 4.85; LR- 0.81).

For panic disorders a four-item panic screening score validated in patients presenting to an ER showed fair LR + (3.44 and 3.89) and poor-to-fair LR- (0.44 and 0.55) \[[@B49]\]. A combination of different questionnaires and pain patterns (Agoraphobia Cognitions Questionnaire; Mobility Inventory for Agoraphobia; McGill Pain Questionnaire sensory) showed a fair LR + (2.6) and fair LR- (0.46) \[[@B50]\]. In patients presenting to their primary care physician with NCCP the presence of a panic disorder was rarely diagnosed. Clinician consultations in this setting had poor accuracy for panic disorder diagnosis (LR + 0.8; LR- 1.02) \[[@B51]\].

Discussion
==========

Main findings
-------------

The included studies showed that most studies investigated tests for gastroesophageal reflux disease (GERD) as the underlying disease in non-cardiovascular chest pain (NCCP). Few studies investigated diagnostic tests for other illnesses. The diagnostic value of a PPI treatment test was confirmed, with a ≥50% symptom reduction under PPI treatment showing posterior sensitivity and specificity of almost 90%. Together with the favorable adverse effect profile of PPIs, a high dose (double reference dose, twice daily) can quickly provide important diagnostic information in patients with unexplained chest pain. History or presence of typical GERD-associated symptoms increases the likelihood of GERD.

Only limited evidence was available for other prevalent illnesses manifesting with chest pain. Screening tools for panic and anxiety disorders are valuable for identifying patients requiring further diagnostic evaluation. The likelihood for musculoskeletal chest pain increased when the pain was reproducible or relieved by pain medication. Among studies investigating musculoskeletal disease, the major limitation was the lack of a reference test ('gold standard').

Results in light of existing literature
---------------------------------------

To the best of our knowledge, this is the first systematic review summarizing the current evidence on the accuracy of diagnostic tests in patients with NCCP. Several non-systematic reviews have suggested various diagnostic and therapeutic approaches \[[@B14],[@B58]-[@B61]\], often with algorithms focused on gastrointestinal diseases \[[@B14],[@B58],[@B59]\], sometimes recommending extensive testing, such as provocation tests. Here, we found no additional value of provocation testing for diagnosing underlying gastroesophageal conditions, as provocation tests failed to identify many patients that would have reflux during a 24-h pH measurement period. While meta-analyses of PPI treatment studies compared to placebo have been previously conducted \[[@B62],[@B63]\], compared to this analyses we excluded studies of poor quality and small sample sizes \[[@B64]-[@B67]\]. Our study is the first to assess study quality and to use a hierarchical Bayesian approach that accounts for within-study and between-study variability and the imperfect nature of the reference test.

Cremonini *et al*. \[[@B62]\] previously used a bivariate model, and found a lower pooled sensitivity and specificity (sensitivity 80% vs 89%, specificity 74% vs 88%) of a positive PPI treatment response for the diagnosis of GERD. Harbord *et al*. \[[@B68]\] showed that the likelihood functions of the two model formulations are algebraically identical in the absence of covariates. However, for assessing a summary ROC curve, the hierarchical Bayesian model is more natural than the model for pooled sensitivity and specificity \[[@B69]\]. Without a broadly accepted standard reference test, it is important to adjust for conditional dependence between multiple tests (index test and reference test) carried out in the same subjects \[[@B69]\]. The hierarchical Bayesian model can be adapted to this situation by introducing covariance terms between the sensitivities and specificities of the index and reference tests. A previous simulation study \[[@B69]\] demonstrated that if a model does not address an imperfect reference test, bias will be around 0.15 in overall sensitivity and specificity \[[@B69]\]. No systematic review has examined diagnostic studies of musculoskeletal chest pain or chest pain as part of a psychiatric disease.

Strengths and limitations
-------------------------

This review comprehensively evaluates the currently available studies. The search was inclusive, no language restrictions were applied, and a thorough bibliographic search was conducted to identify all relevant studies. The extraction process was performed in accordance with current guidelines and supported by an experienced statistician. Potential factors influencing diagnostic test accuracy were identified by a multidisciplinary team (an internist, general practitioner, statistician, and methodologist).

The study was limited by the small number of studies available for most diseases presenting with NCCP. Furthermore, many studies were only of moderate quality and most cross-sectional or prospective studies did not meet the required sample size criterion for reliable estimates of sensitivity and specificity. Small studies on diagnostic accuracy are often imprecise, with wide confidence intervals, making it difficult to assess test informativeness \[[@B17]\]. The lack of a gold standard reference test is another limitation, which we addressed within the Bayesian model formulation; however, the resulting posterior credible intervals for overall sensitivity and specificity of the index test are wider than they would be with a perfect reference test. Further, NCCP is a collective term with potentially different underlying diseases and therefore might present differently. Diagnostic accuracy in one population with high prevalence for one disease is high might be entirely different for another population \[[@B70]\]. Therefore, for most studies no joint meta-analysis could be conducted and results have to be interpreted on a single study level within the context of the study population. We have tried to balance this by providing a thorough description of the studies' inclusion and exclusion criteria and the study setting. This will allow readers to judge to whom study results apply. In studies included in the joint meta-analyses, we intended to include study-specific covariates such as the percentage of female or mean age into the Bayesian model. The inclusion of covariates can reduce unexplained heterogeneity. However, this was due to the small number of studies available for meta-analysis not feasible.

Research implications
---------------------

Further research should investigate the combined value of symptoms, clinical findings, and diagnostic tests, including multidisciplinary research aimed at increasing our knowledge about diagnostic processes and making recommendations for diagnostic tests and treatments in patients with NCCP. Most patients with chest pain consult primary care physicians \[[@B45]\], but few studies are performed in this setting. Further research is needed to strengthen the evidence in a primary care setting. The value of screening questionnaires for panic and anxiety disorders should be further evaluated and investigated in clinical practice. The use of a flag system \[[@B61]\], as successfully applied in back and neck pain, could facilitate the diagnostic process allowing systematic assessment of first red flags (acute disease requiring immediate diagnosis and care), then green flags (identifiable diseases), and yellow flags (psychological diseases).

Implication for practice
------------------------

Patients with NCCP incur high healthcare costs due to the extensive and often invasive diagnostic testing, and NCCP's impact on quality of life. Early identification of underlying diseases is essential to avoid delayed treatment and chronicity of complaints. Symptoms and clinical findings may provide important information to guide treatment of an underlying illness. In patients with typical GERD symptoms, twice-daily high-dose PPI treatment is the most efficient diagnostic approach. GERD is very likely if a positive treatment response occurs after 1 week, while GERD is unlikely if there is no response after 4 weeks of PPI treatment. In patients not responding to PPI, if an endoscopy shows no pathological findings, other illnesses should be considered before initiating further gastrointestinal testing.

Panic and anxiety disorders are often missed in clinical practice \[[@B51]\]. Symptoms such as expressing 'fear of dying', 'light headedness, dizziness, faintness', 'diaphoresis' and 'chills or hot flushes' are associated with anxiety disorders. Screening tests are valuable to rule out panic or anxiety disorders, and positive finding should lead to further investigation.

Conclusions
===========

In patients with NCCP, timely diagnostic evaluation and treatment of the underlying disease is important. A thorough history of symptoms and clinical examination findings can inform clinicians which diagnostic tests are most appropriate. Response to high-dose PPI treatment can indicate whether GERD is the underlying disease and should be considered as an early test. Panic and anxiety disorders are often not diagnosed and should be considered in the differential diagnosis of chest pain.

Appendix 1: Search Strategy May Week 4 2012
===========================================

In Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"} the detailed search strategy of PubMed, Web of Knowledge (INSPEC, Biosis/Biological Abstracts, Web of Science) and OvidSP (Embase, PsycInfo) are given.

###### 

Search Strategy May Week 4 2012 (PubMed)

  **No.**   **Search**                                                                                                                                                                                                 **Hits**
  --------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
  1         Search thoracic pain OR chest pain OR noncardiac chest pain OR non cardiac chest pain OR atypical chest pain OR musculoskeletal chest pain OR esophageal chest pain OR thoracic spine pain OR chest wall   96,313
  2         Search coronary artery disease OR cardiac disease OR coronary heart disease OR coronary thrombosis OR coronary occlusion                                                                                   929,959
  3         Search 1 NOT 2                                                                                                                                                                                             38,735
  4         Search sensitivity OR specificity OR diagnostic tests OR chest pain/diagnosis                                                                                                                              1,301,595
  5         Search 3 AND 4                                                                                                                                                                                             2,736
  6         Search 5 NOT 2; Filters: publication date from 1992/01/01; humans                                                                                                                                          2,177
  7         Search 5 NOT 2; Filters: publication date from 1992/01/01; humans; adult: 19+ years                                                                                                                        1,432

Biological Abstracts/BIOSIS, INSPEC and Web of Science (Web of Knowledge)
-------------------------------------------------------------------------

Topic = ('thoracic pain' OR 'chest pain' OR 'noncardiac chest pain' OR 'non cardiac chest pain' OR 'atypical chest pain' OR 'musculoskeletal chest pain' OR 'esophageal chest pain' OR 'thoracic spine pain' OR 'chest wall') AND Topic = (sensitivity OR specificity OR diagnostic tests) NOT Topic = (coronary artery disease OR cardiac disease OR coronary heart disease OR coronary thrombosis OR coronary occlusion)

Refined by: Topic = (human\*)

Timespan = 1992 to 2012.

###### 

Database: PsycINFO \<1806 to May Week 4 2012\>, Embase \<1974 to 2012 Week 21\> (OvidSP)

  **No.**   **Search**                                                                                                                                                                                                                                                            **Hits**
  --------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------
  1         (thoracic pain or chest pain or noncardiac chest pain or non cardiac chest pain or atypical chest pain or musculoskeletal chest pain or esophageal chest pain or thoracic spine pain or chest wall).mp. \[mp = ti, ab, hw, tc, id, ot, tm, sh, tn, dm, mf, dv, kw\]   44,196
  2         exp thorax pain/di \[Diagnosis\]                                                                                                                                                                                                                                      2,481
  3         exp thorax pain/                                                                                                                                                                                                                                                      36,580
  4         1 or 3                                                                                                                                                                                                                                                                63,756
  5         Coronary artery disease or cardiac disease or coronary heart disease or coronary thrombosis or coronary occlusion).mp. \[mp = ti, ab, hw, tc, id, ot, tm, sh, tn, dm, mf, dv, kw\]                                                                                    222,468
  6         4 not 5                                                                                                                                                                                                                                                               55,961
  7         (sensitivity or specificity or diagnostic tests).mp. \[mp = ti, ab, hw, tc, id, ot, tm, sh, tn, dm, mf, dv, kw\]                                                                                                                                                      1,162,714
  8         2 or 7                                                                                                                                                                                                                                                                1,164,908
  9         6 and 8                                                                                                                                                                                                                                                               4,565
  10        Limit 9 to human                                                                                                                                                                                                                                                      4,180
  11        Limit 10 to year = '1992-Current'                                                                                                                                                                                                                                     3,778
  12        Limit 11 to '300 adulthood \< age 18 years and older \> ' \[Limit not valid in Embase; records were retained\]                                                                                                                                                        3,769
  13        Limit 12 to adulthood \<18+ years \> \[Limit not valid in Embase; records were retained\]                                                                                                                                                                             3,769

Appendix 2: Set up of the hierarchical Bayesian models for the summary receiver operating characteristic (ROC) curves
=====================================================================================================================

Model 1: proton pump inhibitor (PPI) studies

Assumption: imperfect reference standard

Prior distributions:

Prior of prevalence (pi) is beta (12, 12), \<= \> pi in \[0.3, 0.7\]

Prior of beta is uniform (−0.75, 0.75)

Prior of THETA is uniform (−1.5, 1.5)

Prior of LAMBDA is uniform (−3, 3)

Prior of sigma_alpha is uniform (0, 2)

Prior of sigma_theta is uniform (0, 2)

Prior of S2 (sensitivity of reference test) is:

Study(ies) 1 to 7 beta (172.55, 30.45), \<= \> S2 in \[0.8, 0.9\]

Prior of C2 (specificity of reference test) is:

Study(ies) 1 to 7 beta (50.4, 12.6), \<= \> C2 in \[0.7, 0.9\]

Model 2*:* exertional 24 h pH-metry

Assumption: imperfect reference standard

Prior distributions:

Prior of prevalence (pi) is beta (5.2318, 6.0194), \<= \> pi in \[0.18, 0.75\]

Prior of beta is uniform (−0.75, 0.75)

Prior of THETA is uniform (−1.5, 1.5)

Prior of LAMBDA is uniform (−3, 3)

Prior of sigma_alpha is uniform (0, 2)

Prior of sigma_theta is uniform (0, 2)

Prior of S2 (sensitivity of reference test) is:

Study(ies) 1 to 5 beta (172.55, 30.45), \<= \> S2 in \[0.8, 0.9\]

Prior of C2 (specificity of reference test) is:

Study(ies) 1 to 5 beta (50.4, 12.6), \<= \> C2 in \[0.7, 0.9\]

Appendix 3: Summary of excluded studies during full-text review
===============================================================

In Table [5](#T5){ref-type="table"} summarizes the studies reviewed in full-text and excluded from the systematic review. For each study the reason for exclusion is provided.

###### 

Summary of excluded studies during full-text review

  **Author**             **Year**   **Design**                             **Comments**
  ---------------------- ---------- -------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Aanen                  2008       cohort, prospective                    No diagnostic study. No NCCP. GERD, reproducibility of reflux symptoms only
  Abbass                 2009       randomised clinical trial              No diagnostic study. No NCCP. General pain patients
  Achem                  1993       retrospective, review                  Prevalence of nutcracker esophagus in NCCP. For treatment outcome open label trial with small sample
  Achem                  1997       randomised, controlled trial           No diagnostic study. GERD patients only received PPI
  Achem                  2000       review article                         Review article about atypical chest pain
  Adams                  2001       retrospective review                   no NCCP. Spiral CT in pulmonary embolism
  Adamek                 1995       cross-sectional study                  No reference test. Description of coexistence of motility disorders and pathologic acid reflux
  Aikens                 2001       cross-sectional study                  No diagnostic study, presence of fear in NCCP patients. Correlation of fear with symptoms
  Aizawa                 1993       cross-sectional study                  no NCCP, acetylcholine provocation test for coronary arterial spasm
  Ajanovic               1999       cross-sectional study                  no NCCP. Pulmonary embolism
  Aksglaede              2003       experimental                           Experimental. Small sample (n = 5) chest pain.
  Alexander              1994       cross-sectional study                  Prevalence and nature of mental disorders in NCCP and IHD
  Amarasiri              2010       cross-sectional study                  GERD patients not NCCP
  Anzai                  2000       cross-sectional study                  No reference test, coronary flow reserve with dopler in patients with no significant coronary stenosis
  Armstrong              1992       review article                         Review article about atypical chest pain
  Arnold                 2009       randomised clinical trial              No diagnostic study. Treatment outcome
  Aufderheide            1996       validation                             Validation of ACI-TIPI probabilities for MI
  Bak                    1994       cohort, prospective                    No diagnostic study. Comparison of prevalence of findings
  Balaban                1999       experimental                           No diagnostic study. Small sample (n = 10)
  Baniukiewicz           1997       cross-sectional study                  No diagnostic study. Description of findings in upper GI studies
  Barham                 1997       observational                          No NCCP. Description of presence of esophageal spasm in patients undergoing upper GI studies
  Barki                  1996       cohort, prospective                    No diagnostic study. Description of clinical presentation in painful rip syndrome
  Basseri                2011       experimental                           Experimental. No NCCP. Different techniques swallow studies
  Bassotti               1998       cohort, retrospective                  No NCCP. Nutcracker esophagus and the symptoms and findings investigated.
  Bassotti               1992       cohort, prospective                    No diagnostic study. Prevalence
  Beck                   1992       cross-sectional study                  No diagnostic study. Charasteristics of NCCP patients compared to general pain patients
  Belleville             2010       cross-sectional study                  No diagnostic study. Characteristics of patients with panic disorders in the ER
  Berkovich              2000       cohort, retrospective                  No NCCP
  Bernstein              2002       validation                             GOLDmineR: improvement of a risk model
  Berthelot              2005       cohort, retrospective                  No diagnostic study. Pain referral study after injection
  Bjorksten              1999       cross-sectional study                  No patients, workers with muscoloskeletal complaints
  Blatchford             1999       cross-sectional study                  No NCCP. Emergency medical admission rates
  Borjesson              1998       cross-sectional study                  Small sample (n = 18), prevalence of esophageal findings
  Borjesson              1998       non-randomised controlled trial        No diagnostic study. Small sample size (n = 20 per group). Intervention = TENS
  Bortolotti             2001       experimental                           No diagnostic study, small sample (n = 9)
  Bortolotti             1997       randomised clinical trial              No diagnostic study. L-Arginine in patients with NCCP. Small sample (n = 8)
  Bovero                 1993       cohort, prospective                    Duplicate of same study Bovero 1993 included in the analysis under different titel
  Bovero                 1993       cohort, prospective                    Duplicate of same study Bovero 1993 included in the analysis under different titel
  Brims                  2010       review article                         Review article about atypical chest pain
  Broekaert              2006       experimental                           Experimental trial in volunteers (no patients, n = 10)
  Brunse                 2010       cohort, prospective                    No diagnostic study. Prevalence
  Brusori                2001       cross-sectional study                  Mixed sample, diagnosis of esophageal dysmotility in fluoroscopy vs. Manometry
  Budzynski              2010       cross-sectional study                  Mixed patients sample with significant and non significant coronary leasons not responding to PPI treatment
  Bruyninckx             2009       cross-sectional study                  No diagnostic study. GP\'s reasons for referral
  Cameron                2006       case series                            Case series, selected sample by gastroenterologist. Not all patients had all investigation. Small samples for each group
  Cannon                 1994       randomised clinical trial              Treatment outcome (imipramine vs. placebo)
  Carter                 1997       review article                         Review article about atypical chest pain
  Cremonini              2005       review article                         Systematic Review PPI
  Castell                1998       Editorial                              Editorial
  Chambers               1998       observational                          Small sample size: n = 23, SI in 7 patients not calculated
  Cheung                 2007       cross-sectional study                  No diagnostic study. Questionnaire to doctors to see what kind of patients they see, what diagnostic tests they use and how they treat.
  Christenson            2004       cohort, prospective                    Chest discomfort inappropriately not diagnosed ACS. Different research question
  Crichton               1997       experimental                           Experimental statistical rule out
  Cossentino             2012       randomised clinical trial              No diagnostic study. Baclofen in gastro-esophageal diseases
  Dekel                  2003       cohort, retrospective                  No diagnostic study. Prevalence of esophageal motility disorders.
  Dekel                  2004       Not randomised, not controlled trial   PPI trial only 14 patients included (only GERD positive treated)
  Deng                   2009       cross-sectional study                  No NCCP. Combination between cardiac ischemia and esophageal spasms
  De Vries               2006       cross-sectional study                  Mixed patient sample with cardiac and non-cardiac chest pain
  Dickman                2007       cohort, prospective                    No diagnostic study. Prevalence of GI findings in NCCP vs. patients with GERD
  Disla                  1994       cohort, prospective                    No diagnostic study, prevalence
  Domanovits             2002       cross-sectional study                  Rule out cardiovascular disease. No diagnostic study for NCCP
  Ellis                  1992       cohort, prospective                    No diagnostic study. Treatment outcome in patients with esophageal spasm
  Elloway                1992       cross-sectional study                  provocative radionuclide esophagealNo comparison to reference test, radionuclide esophageal transit (P-RET) investigation, small sample (n = 30)
  Elloway                1992       cross-sectional study                  Same study under different title
  Erhardt                2002       Guideline                              Task force on the management of chest pain
  Esayag                 2008       retrospective review                   Pleuritic chest pain. No reference test, description of presentation and outcome
  Esler                  2001       randomized clinical trial              Dissertation, same as following.
  Esler                  2003       randomized clinical trial              Treatment intervention in NCCP. CBT in NCCP seems to reduce chest pain episodes
  Fass                   1999       cohort, prospective                    No diagnostic study. Treatment outcome study
  Fleischmann            1997       cross-sectional study                  No NCCP. Echokardiographic findings in acute chest pain and health status
  Fletcher               2011       cohort, prospective                    Sample size: 8 patients with NCCP
  Fornari                2008       cohort, retrospective                  No NCCP. Only nutcracker esophagus investigated
  Fournier               1993       cross-sectional study                  No NCCP. Ergovine test during coronary angiogram and induction of coronary spasm
  Fournier               1993       cross-sectional study                  Same study under different titles
  Foldes                 2011       cross-sectional study                  No comparison of test with reference test. Prevalence of panic disorders
  Frobert                1996       cross-sectional study                  No diagnostic study. Comparison of characteristics between NCCP with positive treadmill test compared to negative treadmill test.
  Gentile                2003       cross-sectional study                  Patients with pneumococcal pneumonia. No reference test, description of presentation, microbiological findings and mortality
  Gignoux                1993       experimental                           No diagnostic study, experimental study
  Goehler                2011       experimental                           Simulation model of CT scan
  Goodacre               2004       randomized clinical trial              No diagnostic study. Comparison of treatments
  Gustafsson             1997       non-randomised controlled trial        Sample size: intravenous edrophonium chloride test in 16 patients
  Ha                     1998       cross-sectional study                  No only NCCP. Patients with suspected coronary artery spasm. Ergonovine provocation test and scintigrafic findings. Small sample (n = 26)
  Hamm                   2011       Guideline                              ESC Guidelines
  Herbella               2009       cross-sectional study                  No NCCP. Presentation of GERD patients
  Hess                   2008       validation                             Diagnostic accuracy to exclude coronary artery disease
  Hillis                 2003       observational                          Correlation of predictors and long term outcome. No diagnostic study
  Hick                   1992       cohort, retrospective                  No diagnostic study. Comparison of characteristics
  Hirano                 2001       cross-sectional study                  No NCCP. Coronary artery spasm
  Ho                     2001       cross-sectional study                  No diagnostic study. Difference between cardiovascular disease and non-cardiovascular disease
  Hobson                 2006       experimental                           Experimental for pain threshold.
  Hobson                 2006       experimental                           Same study under different titels
  Howarth                2003       cohort, prospective                    Ischemic heart disease and GERD
  Hu                     2000       experimental                           Experimental trial in volunteers
  Hughes                 2007       cohort, retrospective                  No diagnostic study. Risk factors for Reflux or NCCP
  Hung                   2010       review article                         Review article about atypical chest pain
  Ilgen                  2011       validation                             Diagnostic accuracy to exclude coronary artery disease
  Jacobs                 2007       Guideline                              executive summary of management patients with ischemic heart disease
  Jerlock                2005       qualitative study                      No diagnostic study. Qualitative study
  Johnston               1993       cohort, retrospective                  No diagnostic study, prevalence
  Jones                  1999       cross-sectional study                  Pleuritic chest pain. Review article
  Kahrilas               2011       systematic review                      Systematic Review PPI Trial in NCCP, reference publication for included studies
  Kao                    1993       cross-sectional study                  No diagnostic study, prevalence
  Karamanolis            2008       experimental                           Healthy volunteers
  Karlson                1994       observational                          No diagnostic study. Prognosis and outcome after discharge for ER
  Ke                     1993       cohort, prospective                    No diagnostic study, prevalence of GERD in NCCP
  Keefe                  2011       randomised clinical trial              No diagnostic study. Coping skills training, sertraline, placebo
  Keogh                  2004       cross-sectional study                  No diagnostic study. Presence of various psychological factors in the ER in cardiac vs. NCCP on cardiac chest pain
  Kisley                 1997       cohort, prospective                    No diagnostic study. Prognosis after discharge after first admission with acute chest pain
  Klingerman             2011       cross-sectional study                  Rule out cardiovascular disease. No diagnostic study for NCCP
  Klopocka               2005       cohort, prospective                    No diagnostic study. Only 24 patients with NCCP
  Klopocka               2005       cohort, prospective                    Same study under different titles
  Koop                   2005       journal article                        GERD. No diagnostic study in NCCP
  Kumarathurai           2008       cohort, prospective                    No diagnostic study.
  Kushner                1992       cross-sectional study                  small sample: n = 27. Presence of panic disorders in relatives.
  Lacy                   2009       cross-sectional study                  Prevalence study
  Lam                    1994       cohort, prospective                    No diagnostic procedure. Only patients included that chest pain was reproduced during the investigation
  Lanzarini              1994       cross-sectional study                  Description of findings in dobutamine stress echocardiography in patients with positive exercise stress test and negative coronar angiography including ergonovine stress test.
  Lauenbjerg             1997       observational                          No diagnostic study. Long term prognosis in patients with NCCP of various etiologies
  Lee                    2011       randomised clinical trial              Conference proceeding. No diagnostic study
  Lee                    2005       cross-sectional study                  Prevalence study
  Lehtola                2010       randomised, controlled trial           Treatment outcome (manipulation, acupuncture vs. placebo. No diagnostic study
  Lessard                2012                                              Patients with NCCP with Panic disorders. Two different interventions, no diagnostic study
  Lien                   2011       cohort, prospective                    NCCP not investigated
  Lin                    2004       cross-sectional study                  No NCCP. GERD symptoms and underlying conditions. Differences between women and men
  Liu                    2006       cross-sectional study                  No NCCP patients. Correlation analysis between psychological factors and findings
  Lopez Gaston           1994       cross-sectional study                  Only esophageal pain investigated not NCCP
  Lopez Gaston           1994       cross-sectional study                  Same study under different titles
  Lopez Gaston           1994       cross-sectional study                  Same study under different titles
  Loten                  2009       observational                          No diagnostic study. Adverse outcome / prognosis of mixed patient population
  Lyer                   2009       retrospective review                   Spontaneous pneumomediastinum. Presentation and findings. No diagnostic study
  MacPherson             2007       cross-sectional study                  No diagnostic study. Survey of patients after ER diagnosis NCCP about interest in acupuncture
  Maev                   2007       randomised clinical trial              Conference proceeding
  Maev                   2007       randomised clinical trial              Same study under different titles
  Makk                   2000       experimental                           Experimental study. No diagnostic study. Comparison of acid infusion and cardiac vs. non-cardiac chest pain. Small sample
  Manchikanti            2003       observational                          No NCCP. Medial branch blocks for musculoskeletal pain
  Manterola              2004       cross-sectional study                  No diagnostic study. Clinical presentation of patients with NCCP
  Martina                1997       cross-sectional study                  All patients presenting in primary care. NCCP not as subgroup investigated
  Matthews               2005       Meta-analysis                          Meta-analysis for PPI-Trial
  Mayou                  1994       cohort, prospective                    No diagnostic study. Comparison of NCCP vs. IHD patients
  Mayou                  2002       cohort, prospective                    No diagnostic study. One year follow-up in comparison to cardiac chest pain. Comparison of costs to the CVD patients
  Mearin                 1998       cohort study, prospective              No diagnostic study. Change of habits during manometry
  Mehta                  1995       experimental                           No reference test as "true positive" defined.
  Mendelson              1997       cohort, prospective                    Reference test are cancer patients. Comparison of Szintigraphy for the diagnosis of costochondritis
  Mitchell               2006       cross-sectional study                  Prevalence of risk factors and pretest probability
  Miniati                1999       cross-sectional study                  no NCCP. Pulmonary embolism
  Miniati                2001       cross-sectional study                  no NCCP. Pulmonary embolism
  Miniati                2003       cross-sectional study                  no NCCP. Prediction model for pulmonary embolism
  Mujica                 2001       cohort, prospective                    No diagnostic study in patients. Healthy volunteers
  Mulero                 1999       cross-sectional study                  Small sample (n = 24). No reference test. Descriptive findings in SPECT
  Munk                   2008       cohort, prospective                    No diagnostic study. Risk of death in patients with unexplained chest pain
  Nanbu                  1997       cross-sectional study                  Focus on difference between IHD and NCCP patients. Valdity of the medical interview for patients with NCCP
  Nasr                   2010       experimental                           Experimental study.
  Nasr                   2010       experimental                           Same study under different titels
  Nellemann              2000       experimental                           Small sample (n = 5 with chest pain)
  Nevitt                 1999       secondary analysis of an RCT           No NCCP. Vertebral fracture
  Nikolic                2010       cross-sectional study                  No diagnostic study. Comparison of NCCP to IHD patients
  Nilsson                2003       cross-sectional study                  Prevalence of Diagnosis of IHD in primary care.
  Okada                  1993       cross-sectional study                  No NCCP. Provocation of myocardial ischemia by hyperventilation
  Oliver                 1999       cross-sectional study                  CT in acute non-cardiac chest pain. No reference. Description of diagnoses found.
  Pandak                 2002       cross-sectional study                  duplicate of the study included in the analysis
  Panju                  1996       observational                          No diagnostic study. Patients prognosis after discharge
  Paterson               1993       cohort, prospective                    exclude, small sample
  Paterson               1995       cross-sectional study                  No diagnostic study. Description of finding in balloon distention NCCP in comparison to other pain patients
  Paterson               1996       cross-sectional study                  Not enough information to populate a two by two table. Small sample (n = 23)
  Porter-Moffitt         2006       cross-sectional study                  Small sample (Chest pain n = 34). Comparison of findings to other pain diagnosis.
  Rasmussen              2009       cohort, prospective                    No NCCP. Complex regional pain syndrome
  Robertson              2008       cross-sectional study                  Comparison of psychological morbidity in cardiac vs. Non-cardiac chest pain
  Rosano                 1996       randomised clinical trial              No diagnostic study. Treatment of 17-beta-estradiol patches compared to placebo on NCCP in postmenopausal women
  Ratnaike               1993       retrospective review                   No diagnostic study. Audit for IHD
  Rate                   1999       experimental                           healthy volunteers
  Rencoret               2006       cross-sectional study                  No diagnostic study. Prevalence of esophageal disorders in patients with NCCP compared to other GI diseases
  Repasky                2005       validation                             ED chest pain pathway
  Rokkas                 1992       cross-sectional study                  Not enough information to populate the two by two table
  Rose                   1994       cohort, prospective                    No diagnostic study. Does esophageal testing prevent persistence of symptoms? No control group
  Rose                   1994       cohort, prospective                    Same study under different titles
  Rosengren              2008       Editorial                              Editorial
  Rousset                2011       retrospective review                   No NCCP. Catammenial pneumothorax and endometriosis-related pneumothorax
  Ruigomez               2004       cohort study                           No diagnostic study. Description of risk factors, incidence and comorbidities
  Sakata                 1996       cross-sectional study                  No reference test. Description of homeostasis and fibrinolysis in patients with coronary artery spasm. Not sure only NCCP patients
  Sakamoto               2011       cross-sectional study                  Acute chest pain, rule out aortic dissection or pulmonary embolism
  Salles                 2011       cohort, retrospective                  No diagnostic study: SAPHO syndrome, clinical characteristics.
  Sanchis                2008       cross-sectional study                  clinical risk profile of patients with acute chest pain without ST-segment deviation or troponin elevation
  Scarinci               1994       cohort, prospective                    No NCCP. Women with GERD clinical presentation
  Schima                 1992       cohort, prospective                    Small sample (n = 4 NCCP)
  Schima                 1992       cohort, prospective                    Same study under different titles
  Schmidt                2002       cross-sectional study                  No NCCP. General pain patients
  Schmulson              2004       review article                         Review article about atypical chest pain
  Shahid                 2005       cross-sectional study                  No diagnostic study. Prensentation of young adults with chest pain
  Shapiro                2006                                              No NCCP patients. Functional heart burn (pH Man normal) vs. NERD (ph manometry pathologic) incl. psychometric profile).
  Sharma                 2010       experimental                           healthy volunteers
  Shelby                 2009       randomized clinical trial              Same sample as 210 and 217. Description of psychological factors at baseline.
  Sigurdsson             2009       retrospective review                   Retrospective analysis of lung biopsy. No NCCP group
  Singh                  1993       retrospective review                   duplicate of the included study
  Smith                  2000       retrospective review                   Feasibility study based on records in a chiropractic clinic.
  Smout                  1992       experimental                           experimental. Small sample (n = 10)
  Sobralske              2005       review article                         Review article about atypical chest pain
  Spencer                2006       observational                          No NCCP. GI patients long term outcome
  Sporer                 2007       cross-sectional study                  Rule out cardiovascular disease. No diagnostic study for NCCP
  Stahl                  1994       cohort, prospective                    Small sample (n = 13 NCCP patients)
  Steurer                2010       Metaanalysis                           clinical value of diagnostic instruments to rule out IHD
  Stochkendahl           2008       randomised clinical trial              Study protocol
  Stochkendahl           2012       randomised, controlled trial           No diagnostic study. Treatment outcome
  Stochkendahl           2012       randomised, controlled trial           No diagnostic study. Same study as previous. Treatment outcome 1 year follow-up
  Stollman               1997       cross-sectional study                  Small sample (n = 14 patients)
  Taylor                 2002       cross-sectional study                  Rule out strategy cardiovascular patients. No diagnostic study in NCCP
  Taniguchi              2009       cross-sectional study                  Chest pain in asthma. Treatment response to bronchodilatators
  Tew                    1995       cross-sectional study                  No diagnostic study. Outcome cardiovascular patients
  Tougas                 2001       experimental                           Experimental. Autonomic reaction to acid infusion in NCCP patients (n = 28) compared to controls
  Triadafilopoulos       1997       cohort, prospective                    GERD patients. Description of spectrum of patients. Only a few with NCCP
  Tutuian                2006       cross-sectional study                  Not enough information to populate a two by two table in NCCP patients with esophageal spasm
  Valdovinos             2004       experimental                           No reference test. pH Bravo- capsule. Safety, efficacy and experience in 11 patients
  Van Kleef              1995       observational                          No diagnostic study. Intervention success comparison after radiofrequency lesion of the dorsal root ganglion
  Van Peski-Oosterbaan   1998       cross-sectional study                  Survey about how people are interested in psychological treatment after discharge after cardiac unit admission. Mixed patients sample.
  van Ravensteijn        2012       systematic review                      Diagnostic test efficacy in various pain patients
  Varia                  2000       randomised, controlled trial           No diagnostic study. Comparison efficacy Sertraline vs. Placebo.
  Vent                   2010       journal article                        dysphagia cause of chest pain
  Verdon                 2010       observational                          Chest pain early diagnostic guess accuracy in GP's
  Vermeltfoort           2009       cross-sectional study                  Mixed patient sample with cardiac and non-cardiac chest pain
  Volpicelli             2008       cohort, prospective                    Pleural sonography for the diagnosis of pulmonary embolism
  Wang                   2011       cross-sectional study                  Conference proceeding
  Watkins                2011       journal article                        Diagnosis and management of community-acquired pneumonia
  Weiner                 2006       journal article                        Cardiac markers in low-risk patients. No study
  Weingarten             1993       cross-sectional study                  No diagnostic study for NCCP. Reduction of length of stay by complying the guidelines
  White                  2011       cross-sectional study                  no diagnostic study. Prevalence
  Wong                   2002       cohort, prospective                    no comparison to a reference test. Descriptive information only.
  Wulsin                 2002       randomised clinical trial              no diagnostic study. Treatment of paroxetine vs. usual care
  Yelland                2010       review article                         Review article about atypical chest pain
  Yu                     1997       cross-sectional study                  Not enough information to populate a two by two table for symptom index and the presence of GERD
  Zalar                  1995       cross-sectional study                  Conference proceeding
  Zarauza                2003       observational                          No diagnostic study. Follow-up after discharge
  Zheng                  2008       cross-sectional study                  Small sample (n = 27)
  Zheng                  2008       cross-sectional study                  Same study under different title

Appendix 4: Summary of the Scottish Intercollegiate Guidelines Network (SIGN) quality assessment \[[@B19]\]
===========================================================================================================

In Table [6](#T6){ref-type="table"} the study quality assessed by using the Scottish Intercollegiate Guidelines Network (SIGN) methodology checklist for diagnostic studies \[[@B19]\] is summarized. Study quality was assessed by two reviewers independently.

###### 

Summary of the Scottish Intercollegiate Guidelines Network (SIGN) quality assessment \[[@B19]\]

  **Lead author/study**       **1.1**   **1.2**   **1.3**   **1.4**   **1.5**   **1.6**   **1.7**   **1.8**   **1.9**   **1.10**   **1.11**   **1.12**   **1.13**   **2.1**
  -------------------------- --------- --------- --------- --------- --------- --------- --------- --------- --------- ---------- ---------- ---------- ---------- ---------
  Dickman \[[@B31]\]            WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         WC        N/A        ++
  Bautista \[[@B32]\]           WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         WC        N/A        ++
  Fass \[[@B33]\]               WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         WC         WC        ++
  Pandak \[[@B34]\]             WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         PA         PA        \+
  Kim \[[@B35]\]                WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         PA         PA        ++
  Xia \[[@B36]\]                WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         WC         WC        ++
  Kushinir \[[@B37]\]           WC        WC        AA        PA        WC        WC        WC        WC        WC         NA         NA        N/A         PA        \+
  Lacima \[[@B38]\]             WC        PA        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        \+
  Cooke \[[@B39]\]              WC        AA        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        \+
  Bovero \[[@B40]\]             WC        PA        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        \+
  Romand \[[@B41]\]             WC        AA        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        \+
  Abrahao \[[@B42]\]            WC        WC        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        ++
  Ho \[[@B29]\]                 WC        PA        WC        WC        WC        WC        WC        WC        WC         NA         NA         PA         WC        \+
  Kim \[[@B24]\]                WC        WC        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        ++
  Hong \[[@B25]\]               WC        WC        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        ++
  Netzer \[[@B26]\]             WC        AA        WC        WC        WC        WC        WC        PA        WC         NA         NA         WC         WC        \+
  Mousavi \[[@B27]\]            WC        WC        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        ++
  Singh \[[@B28]\]              WC        PA        WC        WC        WC        WC        WC        AA        WC         NA         NA         WC         WC        \+
  Lam \[[@B30]\]                WC        PA        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        \+
  Achem \[[@B43]\]              WC        WC        WC        WC        WC        WC        WC        AA        WC         NA         NA         WC         WC        \+
  Demiryoguran \[[@B48]\]       WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         WC         WC        ++
  Foldes-Busque \[[@B49]\]      WC        WC        WC        WC        WC        WC        WC        WC        AA         WC         NA         WC        N/A        ++
  Kujipers \[[@B47]\]           WC        WC        WC        WC        WC        WC        WC        WC        WC         NA         NA         WC         WC        ++
  Katerndahl \[[@B51]\]         WC        AA        WC        WC        WC        WC        WC        WC        WC         WC         WC         WC         WC        ++
  Fleet \[[@B50]\]              WC        WC        WC        WC        WC        WC        WC        WC        WC         WC         WC         WC         WC        ++
  Stochkendahl \[[@B44]\]       WC        WC        WC        NA        WC        WC        PA        WC        WC         NA         NA         WC         WC        \+
  Manchikanti \[[@B46]\]        WC        WC        WC        WC        PA        PA        WC        WC        WC         WC         PA         PA         WC        \+
  Bosner \[[@B45]\]             WC        WC        WC        WC        WC        WC        WC        AA        WC         WC         AA         WC         WC        ++

1.1: spectrum of patients is representative of patients who will receive the test; 1.2: selection criteria described; 1.3: reference standard is likely to classify the condition correctly; 1.4: period between reference standard and index test short enough; 1.5: whole sample received verification of diagnosis; 1.6: patients receive same reference test regardless of index test results; 1.7: reference standard independent of index test; 1.8: execution of index test described in detail; 1.9: reference standard described in detail; 1.10: index test interpreted without knowledge of result of reference test; 1.11: reference standard results interpreted without knowledge of result index test; 1.12: uninterpretable or intermediate results are reported; 1.13: explanation is provided for withdrawals; 2.1: reliability of the conclusion of the study. Risk of bias (2.1) is as follows. (++), high quality: most of the criteria have been fulfilled. If not fulfilled, the conclusions of the study are very unlikely to alter. (+), moderate quality: some criteria fulfilled. Criteria not adequately described are unlikely to alter the conclusions. (−), low quality: few or no criteria fulfilled. The conclusions are likely to alter.

*AA* adequately addressed, *N/A* not applicable, *NA* not addressed, *NR* not reported, *PA* poorly addressed, *WC* well covered.

Appendix 5: Summary of all tests evaluated
==========================================

Table [7](#T7){ref-type="table"} provides a detailed description of all tests and reference tests investigated. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), prevalence, and post test prevalence are given.

###### 

Summary of all tests evaluated

  **Criteria**                        **Evaluated test**                                                                                                                                                                                       **Reference standard**                                                                                                                                                    **TP**   **FP**   **FN**   **TN**   **Sensitivity**   **Specificity**   **PPV**   **NPV**   **LR+**   **LR-**   **Prevalence**   **Post-test + prevalence**   **Post-test - prevalence**
  ----------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------- -------- -------- -------- ----------------- ----------------- --------- --------- --------- --------- ---------------- ---------------------------- ----------------------------
  Symptoms                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Kim *et al*. \[[@B24]\]             NCCP with atypical GERD symptoms                                                                                                                                                                         Endoscopy (LA classification) and/or 24 h pH-metry (\>4%, pH \<4                                                                                                          3        20       5        6        0.38              0.23              0.13      0.55      0.49      2.71      24               13                           45
  Kim *et al*. \[[@B24]\]             NCCP with typical GERD symptoms                                                                                                                                                                          Endoscopy (LA classification) and/or 24 h pH-metry (\>4%, pH \<4                                                                                                          11       2        5        6        0.69              0.75              0.85      0.55      2.75      0.42      67               85                           45
  Mousavi *et al*. \[[@B27]\]         NCCP with typical GERD symptoms                                                                                                                                                                          GERD if two tests positive: endoscopy (Hentzel-Dent), Bernstein test, omeprazole trial                                                                                    11       5        24       38       0.31              0.88              0.69      0.61      2.70      0.78      45               69                           39
  Mousavi *et al*. \[[@B27]\]         NCCP relieved by antacid                                                                                                                                                                                 GERD if two tests positive: endoscopy (Hentzel-Dent), Bernstein test, omeprazole trial                                                                                    15       36       20       7        0.43              0.16              0.68      0.64      0.51      3.51      45               29                           74
  Mousavi *et al*. \[[@B27]\]         NCCP and heartburn in history                                                                                                                                                                            GERD if two tests positive: endoscopy (Hentzel-Dent), Bernstein test, omeprazole trial                                                                                    14       8        21       35       0.40              0.81              0.64      0.63      2.15      0.74      45               64                           38
  Mousavi *et al*. \[[@B27]\]         NCCP and regurgitation in history                                                                                                                                                                        GERD if two tests positive: endoscopy (Hentzel-Dent), Bernstein test, omeprazole trial                                                                                    17       7        18       36       0.49              0.84              0.71      0.67      2.98      0.61      45               71                           33
  Hong *et al*. \[[@B25]\]            NCCP                                                                                                                                                                                                     Manometry (Specler 2001 criteria) and/or 24 h pH-metry (\>4% pH \<4)                                                                                                      72       114      128      148      0.36              0.56              0.39      0.54      0.83      1.13      43               39                           46
  Hong *et al*. \[[@B25]\]            Control: dysphagia                                                                                                                                                                                       Manometry (Specler 2001 criteria) and/or 24 h pH-metry (\>4% pH \<4)                                                                                                      27       26       181      228      0.13              0.90              0.51      0.56      1.27      0.97      45               51                           44
  Hong *et al*. \[[@B25]\]            Control: GERD-typical symptoms                                                                                                                                                                           Manometry (Specler 2001 criteria) and/or 24 h pH-metry (\>4% pH \<4)                                                                                                      53       53       151      205      0.26              0.79              0.50      0.58      1.26      0.93      44               50                           42
  Hong *et al*. \[[@B25]\]            Dysphagia                                                                                                                                                                                                Manometry                                                                                                                                                                 16       37       84       325      0.16              0.90              0.30      0.80      1.57      0.94      22               30                           21
  Hong *et al*. \[[@B25]\]            Dysphagia                                                                                                                                                                                                24 h pH-metry                                                                                                                                                             4        49       63       346      0.06              0.88              0.08      0.85      0.48      1.07      15               8                            15
  Hong *et al*. \[[@B25]\]            Dysphagia                                                                                                                                                                                                Manometry and 24 h pH-metry                                                                                                                                               7        46       23       386      0.23              0.89              0.13      0.94      2.19      0.86      7                13                           6
  Hong *et al*. \[[@B25]\]            NCCP                                                                                                                                                                                                     Manometry                                                                                                                                                                 34       152      63       213      0.35              0.58              0.18      0.77      0.84      1.11      21               18                           23
  Hong *et al*. \[[@B25]\]            NCCP                                                                                                                                                                                                     24 h pH-metry                                                                                                                                                             29       157      43       233      0.40              0.60              0.16      0.60      1.00      1.00      16               16                           16
  Hong *et al*. \[[@B25]\]            NCCP                                                                                                                                                                                                     Manometry and 24 h pH-metry                                                                                                                                               9        177      22       254      0.29              0.59              0.05      0.92      0.71      1.20      7                5                            8
  Hong *et al*. \[[@B25]\]            GERD-typical symptoms                                                                                                                                                                                    Manometry                                                                                                                                                                 19       87       81       275      0.19              0.76              0.18      0.77      0.79      1.07      22               18                           23
  Hong *et al*. \[[@B25]\]            GERD-typical symptoms                                                                                                                                                                                    24 h pH-metry                                                                                                                                                             23       83       49       307      0.32              0.79              0.22      0.86      1.50      0.86      16               22                           14
  Hong *et al*. \[[@B25]\]            GERD-typical symptoms                                                                                                                                                                                    Manometry and 24 h pH-metry                                                                                                                                               11       95       20       336      0.35              0.78              0.10      0.94      1.61      0.83      7                10                           6
  Netzer *et al*. \[[@B26]\]          NCCP                                                                                                                                                                                                     Manometry and/or 24 h pH-metry (\>10.5% pH \<4)                                                                                                                           31       14       223      35       0.12              0.71              0.69      0.14      0.43      1.23      84               69                           86
  Netzer *et al*. \[[@B26]\]          Control: GERD-typical symptoms                                                                                                                                                                           Manometry and/or 24 h pH-metry (\>10.5% pH \<4)                                                                                                                           127      16       127      33       0.50              0.67              0.89      0.21      1.53      0.74      84               89                           79
  Netzer *et al*. \[[@B26]\]          Control: dysphagia                                                                                                                                                                                       Manometry and/or 24 h pH-metry (\>10.5% pH \<4)                                                                                                                           48       8        206      41       0.19              0.84              0.86      0.17      1.16      0.97      84               86                           83
  Netzer *et al*. \[[@B26]\]          GERD-typical symptoms                                                                                                                                                                                    24 h pH-metry                                                                                                                                                             115      28       49       111      0.70              0.80              0.80      0.69      3.48      0.37      54               80                           31
  Netzer *et al*. \[[@B26]\]          Dysphagia                                                                                                                                                                                                24 h pH-metry                                                                                                                                                             6        50       158      89       0.04              0.64              0.11      0.36      0.10      1.50      54               11                           64
  Netzer *et al*. \[[@B26]\]          NCCP                                                                                                                                                                                                     24 h pH-metry                                                                                                                                                             24       21       140      118      0.15              0.85              0.53      0.46      0.97      1.01      54               53                           54
  PPI trial                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Dickman *et al*. \[[@B31]\]         Rabeprazole 20 mg twice a day for 1 week SIS ≥50%                                                                                                                                                        Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                      12       2        4        17       0.75              0.89              0.86      0.81      7.13      0.28      46               86                           19
  Dickman *et al*. \[[@B31]\]         Placebo for 1 week                                                                                                                                                                                       Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                      3        4        13       15       0.19              0.79              0.43      0.54      0.89      1.03      46               43                           46
  Bautista *et al*. \[[@B32]\]        Lansoprazole 60 mg AM, 30 mg PM for 1 week SIS ≥50%                                                                                                                                                      Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                      14       2        4        20       0.78              0.91              0.875     0.833     8.56      0.24      45               88                           17
  Bautista *et al*. \[[@B32]\]        Lansoprazole 60 mg AM, 30 mg PM for 1 week SIS ≥65%                                                                                                                                                      Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                      15       1        3        21       0.83              0.95              0.93      0.88      18.33     0.17      45               94                           13
  Bautista *et al*. \[[@B32]\]        Placebo for 1 week                                                                                                                                                                                       Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                      4        8        14       14       0.22              0.64              0.33      0.50      0.61      1.22      45               33                           50
  Fass *et al*. \[[@B33]\]            Omeprazole 40 mg AM, 20 mg PM for 1 week SIS ≥50%                                                                                                                                                        Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                      18       2        5        12       0.78              0.86              0.90      0.71      5.48      0.25      62               90                           29
  Fass *et al*. \[[@B33]\]            Placebo for 1 week                                                                                                                                                                                       Endoscopy (Hentzel-Dent grades) and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                      5        1        18       13       0.22              0.93              0.83      0.42      3.04      0.84      62               83                           58
  Pandak *et al*. \[[@B34]\]          Omeprazole 40 mg twice a day for 2 weeks SIS ≥50%                                                                                                                                                        Endoscopy and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                                            18       6        2        12       0.90              0.67              0.75      0.86      2.70      0.15      53               75                           14
  Pandak *et al*. \[[@B34]\]          Placebo for 2 weeks SIS ≥50%                                                                                                                                                                             Endoscopy and/or 24 h pH-metry (\>4.2% pH \<4)                                                                                                                            1        3        19       15       0.05              0.83              0.25      0.44      0.30      1.14      53               25                           56
  Kim *et al*. \[[@B35]\]             NCCP GERD-related (TP) vs NCCP non-GERD-related (TN): rabeprazole for 1 week SIS ≥50%                                                                                                                    Endoscopy (LA classification) and/or 24 h pH-metry (\>4.0 pH \<4)                                                                                                         8        6        8        20       0.50              0.77              0.57      0.71      2.17      0.65      38               57                           29
  Kim *et al*. \[[@B35]\]             NCCP GERD-related (TP) vs NCCP non-GERD-related (TN): rabeprazole for 2 weeks SIS ≥50%                                                                                                                   Endoscopy (LA classification) and/or 24 h pH-metry (\>4.0 pH \<4)                                                                                                         13       7        3        19       0.81              0.73              0.65      0.86      3.02      0.26      38               65                           14
  Xia *et al*. \[[@B36]\]             Lansoprazole 30 mg once a day for 4 weeks SIS ≥50%                                                                                                                                                       24 h pH-metry (De Meester pH \<4, 7.5 s)                                                                                                                                  11       8        1        16       0.92              0.67              0.58      0.94      2.75      0.13      33               58                           6
  Xia *et al*. \[[@B36]\]             Placebo for 4 weeks SIS ≥50%                                                                                                                                                                             24 h pH-metry (De Meester pH \<4, 7.5 s)                                                                                                                                  4        7        8        13       0.33              0.65              0.36      0.62      0.95      1.03      38               36                           38
  Kushnir *et al*. \[[@B37]\]         High-degree response on PPI (not specified)                                                                                                                                                              24 pH-metry (≥4%, pH \<4)                                                                                                                                                 40       18       12       28       0.77              0.61              0.69      0.70      1.97      0.38      53               69                           30
  Kushnir *et al*. \[[@B37]\]         High-degree response on PPI                                                                                                                                                                              Positive Ghillibert probability estimate (GPE)                                                                                                                            21       37       5        35       0.81              0.49              0.36      0.88      1.57      0.40      27               36                           12
  Kushnir *et al*. \[[@B37]\]         High-degree response on PPI                                                                                                                                                                              Association of chest pain with pH \<4 in reference standard: SI ≥50%                                                                                                      19       39       6        34       0.76              0.47              0.33      0.85      1.42      0.52      26               33                           15
  Kushnir *et al*. \[[@B37]\]         High-degree response on PPI                                                                                                                                                                              24 h pH-metry and positive GPE                                                                                                                                            15       43       2        38       0.88              0.47              0.26      0.95      1.66      0.25      17               26                           5
  Kushnir *et al*. \[[@B37]\]         High-degree response on PPI                                                                                                                                                                              24 h pH-metry and SI ≥50%                                                                                                                                                 16       42       2        38       0.89              0.48              0.28      0.95      1.69      0.23      18               28                           5
  Kushnir *et al*. \[[@B37]\]         High-degree response on PPI                                                                                                                                                                              24 h pH-metry and SI ≥50% and positive GPE                                                                                                                                14       44       1        39       0.93              0.47              0.24      0.98      1.76      0.14      15               24                           2
  Symptom index                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  Singh *et al*. \[[@B28]\]           Association of chest pain with pH \<4 in reference standard: SI ≥50%                                                                                                                                     Endoscopy and/or 24 h pH-metry (De Meester \>5.5% pH \<4)                                                                                                                 19       38       15       81       0.56              0.68              0.33      0.84      1.75      0.65      22               33                           16
  Singh *et al*. \[[@B28]\]           Association of chest pain with pH \<4 in reference standard: SI ≥25%                                                                                                                                     Endoscopy and/or 24 h pH-metry (De Meester \>5.5% pH \<4)                                                                                                                 23       59       11       60       0.68              0.50              0.28      0.85      1.36      0.64      22               28                           15
  Singh *et al*. \[[@B28]\]           Association of chest pain with pH \<4 in reference standard: SI ≥75%                                                                                                                                     Endoscopy and/or 24 h pH-metry (De Meester \>5.5% pH \<4)                                                                                                                 8        5        26       114      0.24              0.96              0.62      0.81      5.60      0.80      22               62                           19
  Singh *et al*. \[[@B28]\]           Association of heartburn with pH \<4 in reference standard: Symptom Index (SI) ≥50%                                                                                                                      Endoscopy and/or 24 h pH-metry (De Meester \>5.5% pH \<4)                                                                                                                 40       32       3        78       0.93              0.71              0.56      0.96      3.20      0.10      28               56                           4
  Singh *et al*. \[[@B28]\]           Association of heartburn with pH \<4 in reference standard: SI ≥25%                                                                                                                                      Endoscopy and/or 24 h pH-metry (De Meester \>5.5% pH \<4)                                                                                                                 41       40       2        70       0.95              0.64              0.51      0.97      2.62      0.07      28               51                           3
  Singh *et al*. \[[@B28]\]           Association of heartburn with pH \<4 in reference standard: SI ≥75%                                                                                                                                      Endoscopy and/or 24 h pH-metry (De Meester \>5.5% pH \<4)                                                                                                                 25       25       9        94       0.74              0.79              0.50      0.91      3.50      0.34      28               58                           12
  Ho *et al*. \[[@B29]\]              Association of chest pain with pH \<4 in reference standard: SI \>50%                                                                                                                                    24 h pH-metry (\>4% pH \<4, 4 s)                                                                                                                                          3        9        11       38       0.21              0.81              0.25      0.78      1.12      0.97      23               25                           22
  Lam *et al*. \[[@B30]\]             Association of chest pain with pH \<4 in reference standard: SI ≥75%                                                                                                                                     24 h pH-metry (execution in acute stage)                                                                                                                                  13       0        15       13       0.46              1.00              1.00      0.48      13.03     0.54      68               97                           54
  Others                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Lacima *et al*. \[[@B38]\]          24 h-manometry (pH \<4)                                                                                                                                                                                  Manometry during hospital stay                                                                                                                                            18       24       18       30       0.50              0.56              0.43      0.56      1.13      0.90      40               43                           38
  Provocation test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Cooke *et al*. \[[@B39]\]           NCCP during exertional pH-metry                                                                                                                                                                          24 h pH-metry (5.5% pH \<4 for 10 s)                                                                                                                                      4        0        15       31       0.21              1.00              1.00      0.67      14.40     0.79      38               90                           33
  Cooke *et al*. \[[@B39]\]           Control group: CVD with angina: exertional pH-metry                                                                                                                                                      24 h pH-metry (5.5% pH \<4 for 10 s)                                                                                                                                      1        1        2        12       0.33              0.92              0.50      0.86      4.33      0.72      19               50                           14
  Bovero *et al*. \[[@B40]\]          NCCP with normal ECG during exertional pH-metry                                                                                                                                                          24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                       17       1        29       20       0.37              0.95              0.94      0.41      7.76      0.66      69               94                           59
  Bovero *et al*. \[[@B40]\]          NCCP at rest: NCCP with normal ECG during exertional pH-metry                                                                                                                                            24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                       11       1        23       11       0.32              0.92              0.92      0.32      3.88      0.74      74               92                           68
  Bovero *et al*. \[[@B40]\]          NCCP exertion/mixed: NCCP with normal ECG during exertional pH-metry                                                                                                                                     24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                       6        0        6        9        0.50              1.00              1.00      0.60      10.00     0.50      57               93                           40
  Bovero *et al*. \[[@B40]\]          24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                                                      NCCP with normal ECG during exertional pH-metry                                                                                                                           17       29       1        20       0.94              0.41              0.37      0.95      1.60      0.14      27               37                           5
  Bovero *et al*. \[[@B40]\]          24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                                                      NCCP at rest: NCCP with normal ECG during exertional pH-metry                                                                                                             11       23       1        11       0.92              0.32              0.32      0.92      1.36      0.26      26               32                           8
  Romand *et al*. \[[@B41]\]          NCCP: pH \<4 for 10 s during exertional pH-metry                                                                                                                                                         24 h pH-metry (De Meester criteria: \>4.5% pH \<4))                                                                                                                       7        14       3        19       0.70              0.58              0.33      0.86      1.65      0.52      23               33                           14
  Abrahao *et al*. \[[@B42]\]         NCCP reproducible during balloon distension                                                                                                                                                              Endoscopy (Savary-Miller) and/or manometry and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                            14       1        21       4        0.40              0.80              0.93      0.16      2.00      0.75      88               93                           84
  Abrahao *et al*. \[[@B42]\]         NCCP reproducible during Tensilon test                                                                                                                                                                   Endoscopy (Savary-Miller) and/or manometry and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                            6        2        29       3        0.17              0.60              0.75      0.09      0.43      1.38      88               75                           91
  Abrahao *et al*. \[[@B42]\]         NCCP reproducible during Bernstein test                                                                                                                                                                  Endoscopy (Savary-Miller) and/or manometry and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                            9        1        26       4        0.26              0.80              0.90      0.13      1.29      0.93      88               90                           87
  Abrahao *et al*. \[[@B42]\]         Tensilon and Bernstein Test and balloon distension (+ if 1 test +)                                                                                                                                       Endoscopy (Savary-Miller) and/or manometry and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                            20       3        15       2        0.57              0.40              0.87      0.12      0.95      1.07      88               87                           88
  Abrahao *et al*. \[[@B42]\]         NCCP reproducible during Tensilon test                                                                                                                                                                   Endoscopy (Savary-Miller) and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                                             6        2        26       6        0.19              0.75              0.75      0.19      0.75      1.08      80               75                           81
  Abrahao *et al*. \[[@B42]\]         NCCP reproducible during Bernstein test                                                                                                                                                                  Endoscopy (Savary-Miller) and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                                             8        2        24       6        0.25              0.75              0.80      0.20      1.00      1.00      80               80                           80
  Abrahao *et al*. \[[@B42]\]         NCCP reproducible during balloon distension                                                                                                                                                              Endoscopy (Savary-Miller) and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                                             13       2        19       6        0.41              0.75              0.87      0.24      1.63      0.79      80               87                           76
  Abrahao *et al*. \[[@B42]\]         Tensilon and Bernstein Test and balloon distension (+ if 1 test +)                                                                                                                                       Endoscopy (Savary-Miller) and/or pH-metry (De Meester criteria: \>4.5% pH \<4                                                                                             18       5        14       3        0.56              0.38              0.78      0.18      0.90      1.17      80               78                           82
  Ho *et al*. \[[@B29]\]              NCCP reproducible during Bernstein test                                                                                                                                                                  Endoscopy                                                                                                                                                                 4        7        3        56       0.57              0.89              0.36      0.95      5.14      0.48      10               36                           5
  Eosinophilia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Achem *et al*. \[[@B43]\]           Current GERD symptoms                                                                                                                                                                                    Esophageal biopsies                                                                                                                                                       10       26       14       121      0.42              0.82              0.28      0.90      2.36      0.71      14               28                           10
  Achem *et al*. \[[@B43]\]           Male gender or current GERD symptoms                                                                                                                                                                     Esophageal biopsies                                                                                                                                                       18       69       6        78       0.75              0.53              0.21      0.93      1.60      0.47      14               21                           7
  Achem *et al*. \[[@B43]\]           Male gender or any abnormal EoE endoscopic finding                                                                                                                                                       Esophageal biopsies                                                                                                                                                       23       79       1        68       0.96              0.46              0.23      0.99      1.78      0.09      14               23                           1
  Achem *et al*. \[[@B43]\]           Current GERD symptoms or any abnormal EoE endoscopic finding                                                                                                                                             Esophageal biopsies                                                                                                                                                       20       63       4        84       0.83              0.57              0.24      0.96      1.94      0.29      14               24                           5
  Musculoskeletal                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Stochkendahl *et al*. \[[@B44]\]    Biomechanical dysfunction                                                                                                                                                                                Standardized examination protocol                                                                                                                                         112      120      0        70       1.00              0.37              0.48      1.00      1.58      0.00      37               48                           0
  Stochkendahl *et al*. \[[@B44]\]    ≥3 of 5 overall palpation findings                                                                                                                                                                       Standardized examination protocol                                                                                                                                         111      124      1        66       0.99              0.35              0.47      0.99      1.52      0.03      37               47                           1
  Bosner *et al*. \[[@B45]\]          Chest wall symptom (CWS) score: localized muscle tension, stinging pain, pain reproducible by palpation, absence of cough, cut-off test negative 0 to 1 points                                           Interdisciplinary consensus: cardiologist, GP, research associate (based on reviewed baseline, follow-up data)                                                            506      318      59       329      0.90              0.51              0.66      0.82      1.82      0.20      47               61                           15
  Bosner *et al*. \[[@B45]\]          CWS score: localized muscle tension, stinging pain, pain reproducible by palpation, absence of cough, cut-off test negative 0 to 2 points                                                                Interdisciplinary consensus                                                                                                                                               357      135      208      512      0.63              0.79              0.76      0.67      3.02      0.47      47               72                           29
  Stochkendahl *et al*. \[[@B44]\]    Anterior chest wall tenderness                                                                                                                                                                           Standardized examination protocol                                                                                                                                         110      134      2        56       0.98              0.29              0.45      0.97      1.39      0.06      37               45                           3
  Stochkendahl *et al*. \[[@B44]\]    Angina pectoris (uncertain or negative)                                                                                                                                                                  Standardized examination protocol                                                                                                                                         109      147      3        43       0.97              0.23              0.43      0.94      1.26      0.12      37               43                           7
  Stochkendahl *et al*. \[[@B44]\]    Pain worse on movement of torso                                                                                                                                                                          Standardized examination protocol                                                                                                                                         32       16       80       174      0.29              0.92              0.67      0.69      3.39      0.78      37               67                           32
  Bosner *et al*. \[[@B45]\]          Pain worse with movement                                                                                                                                                                                 Interdisciplinary consensus                                                                                                                                               221      119      344      528      0.39              0.82              0.65      0.61      2.13      0.75      47               65                           40
  Stochkendahl *et al*. \[[@B44]\]    Positive/possible belief in pain origin from muscle/joints                                                                                                                                               Standardized examination protocol                                                                                                                                         108      156      4        34       0.96              0.18              0.41      0.90      1.17      0.20      37               41                           11
  Stochkendahl *et al*. \[[@B44]\]    Pain relief on pain medication                                                                                                                                                                           Standardized examination protocol                                                                                                                                         25       13       87       177      0.22              0.93              0.66      0.67      3.26      0.83      37               66                           33
  Bosner *et al*. \[[@B45]\]          Pain reproducible by palpation                                                                                                                                                                           Interdisciplinary consensus                                                                                                                                               351      193      214      454      0.62              0.70              0.68      0.64      2.08      0.54      47               65                           32
  Stochkendahl *et al*. \[[@B44]\]    Paraspinal tenderness                                                                                                                                                                                    Standardized examination protocol                                                                                                                                         90       112      22       78       0.80              0.41              0.45      0.78      1.36      0.48      37               45                           22
  Bosner *et al*. \[[@B45]\]          Localized muscle tension                                                                                                                                                                                 Interdisciplinary consensus                                                                                                                                               346      164      219      483      0.61              0.75              0.71      0.66      2.41      0.52      47               68                           32
  Stochkendahl *et al*. \[[@B44]\]    Chest pain present now                                                                                                                                                                                   Standardized examination protocol                                                                                                                                         92       116      20       74       0.82              0.39              0.44      0.79      1.35      0.46      37               44                           21
  Bosner *et al*. \[[@B45]\]          Pain now                                                                                                                                                                                                 Interdisciplinary consensus                                                                                                                                               328      327      237      320      0.58              0.49              0.50      0.57      1.15      0.85      47               50                           43
  Stochkendahl *et al*. \[[@B44]\]    Pain debut not during a meal                                                                                                                                                                             Standardized examination protocol                                                                                                                                         109      168      3        22       0.97              0.12              0.39      0.88      1.10      0.23      37               39                           12
  Stochkendahl *et al*. \[[@B44]\]    Sharp pain                                                                                                                                                                                               Standardized examination protocol                                                                                                                                         39       35       73       155      0.35              0.82              0.53      0.68      1.89      0.80      37               53                           32
  Bosner *et al*. \[[@B45]\]          Stinging pain                                                                                                                                                                                            Interdisciplinary consensus                                                                                                                                               299      184      266      463      0.53              0.72              0.62      0.63      1.87      0.66      47               62                           37
  Stochkendahl *et al*. \[[@B44]\]    Hard physical exercise at least once a week                                                                                                                                                              Standardized examination protocol                                                                                                                                         42       60       70       130      0.38              0.68              0.41      0.65      1.19      0.91      37               41                           35
  Stochkendahl *et al*. \[[@B44]\]    Pain not provoked during a meal                                                                                                                                                                          Standardized examination protocol                                                                                                                                         109      170      3        20       0.97              0.11              0.39      0.87      1.09      0.25      37               39                           13
  Stochkendahl *et al*. \[[@B44]\]    Not sudden debut                                                                                                                                                                                         Standardized examination protocol                                                                                                                                         53       31       59       159      0.47              0.84              0.63      0.73      2.90      0.63      37               63                           27
  Bosner *et al*. \[[@B45]\]          Pain \>24 h                                                                                                                                                                                              Interdisciplinary consensus                                                                                                                                               158      139      407      508      0.28              0.79              0.53      0.56      1.30      0.92      47               54                           45
  Stochkendahl *et al*. \[[@B44]\]    Age ≤49 years old                                                                                                                                                                                        Standardized examination protocol                                                                                                                                         67       54       45       136      0.60              0.72              0.55      0.75      2.10      0.56      37               55                           25
  Bosner *et al*. \[[@B45]\]          Pain mostly at noon time                                                                                                                                                                                 Interdisciplinary consensus                                                                                                                                               13       30       552      617      0.02              0.95              0.31      0.53      0.50      1.02      47               31                           48
  Bosner *et al*. \[[@B45]\]          Cough                                                                                                                                                                                                    Interdisciplinary consensus                                                                                                                                               31       129      534      518      0.06              0.80              0.19      0.49      0.28      1.18      47               20                           51
  Bosner *et al*. \[[@B45]\]          Known IHD                                                                                                                                                                                                Interdisciplinary consensus                                                                                                                                               56       122      509      525      0.10              0.81              0.32      0.51      0.52      1.11      47               32                           50
  Bosner *et al*. \[[@B45]\]          Pain worse with breathing                                                                                                                                                                                Interdisciplinary consensus                                                                                                                                               138      123      427      524      0.24              0.81              0.53      0.55      1.28      0.93      47               53                           45
  Manchikanti *et al*. \[[@B46]\]     Chronic thoracic pain: lidocaine injection                                                                                                                                                               Bupivacaine injection                                                                                                                                                     22       14       \_       \_                                           0.61      \_                                                                           
  Psychiatric                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Kuijpers *et al*. \[[@B47]\]        Anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A score, cut-off ≥8)                                                                                                                 Diagnosis Anxiety disorders (Mini International Neuropsychiatric Interview (gold standard))                                                                               195      71       3        75       0.98              0.51              0.73      0.96      2.03      0.03      58               73                           4
  Demiryoguran *et al*. \[[@B48]\]    Palpitation                                                                                                                                                                                              Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                              18       25       31       80       0.37              0.76              0.42      0.72      1.54      0.83      31               41                           27
  Demiryoguran *et al*. \[[@B48]\]    Fear of dying                                                                                                                                                                                            Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                              11       6        38       102      0.22              0.94              0.65      0.73      4.04      0.82      31               65                           27
  Demiryoguran *et al*. \[[@B48]\]    Light-headedness, dizziness, faintness                                                                                                                                                                   Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                              11       8        38       100      0.22              0.93              0.58      0.73      3.03      0.84      31               58                           28
  Demiryoguran *et al*. \[[@B48]\]    Chills or hot flushes                                                                                                                                                                                    Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                              11       5        38       103      0.22              0.95              0.69      0.73      4.85      0.81      31               69                           27
  Demiryoguran *et al*. \[[@B48]\]    Shortness of breath                                                                                                                                                                                      Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                              13       22       36       86       0.27              0.80              0.37      0.71      1.30      0.92      31               37                           29
  Demiryoguran *et al*. \[[@B48]\]    Nausea or gastric discomfort                                                                                                                                                                             Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                              9        10       40       98       0.18              0.91              0.47      0.71      1.98      0.90      31               47                           29
  Demiryoguran *et al*. \[[@B48]\]    Diaphoresis                                                                                                                                                                                              Anxiety disorder: HADS-A score (cut-off ≥10)                                                                                                                              19       12       30       96       0.39              0.89              0.61      0.76      3.49      0.69      31               61                           24
  Foldes-Busque *et al*. \[[@B49]\]   The Panic Screening Score (derivation population)                                                                                                                                                        Panic disorder diagnosis (structured Anxiety Disorders Interview Schedule for *Diagnostic and Statistical Manual of Mental Disorders*, fourth edition DSM-IV (ADIS-IV))   53       19       31       98       0.63              0.84              0.74      0.76      3.89      0.44      42               74                           24
  Foldes-Busque *et al*. \[[@B49]\]   The Panic Screening Score (validation population)                                                                                                                                                        Panic disorder diagnosis (structured ADIS-IV)                                                                                                                             69       27       61       148      0.53              0.85              0.72      0.71      3.44      0.55      43               72                           29
  Katerndahl *et al*. \[[@B51]\]      GP diagnosis of panic disorder                                                                                                                                                                           Panic disorder (structured clinical Interview of *Diagnostic and Statistical Manual of Mental Disorders*, based on DSM-III-R)                                             2        2        26       21       0.07              0.91              0.50      0.45      0.82      1.02      55               50                           55
  Fleet *et al*. \[[@B50]\]           Panic disorder diagnosis: formula including Agoraphobia Cognitions QA, Mobility Inventory for Agoraphobia, Zone 12 Dermatome Pain Map, Sensory McGill Pain QA, Gender, Zone 25 (Validation population)   Panic Disorder (ADIS-R structured interview by psychologist)                                                                                                              32       41       17       122      0.65              0.75              0.44      0.88      2.60      0.46      23               44                           12

Sensitivity calculated by TP/(TP + FN); specificity calculated by TN/(FP + TN). Biomechanical dysfunction defined as chest pain presumably caused by mechanical joint and muscle dysfunction related to C4 to T8 somatic structures of the spine and chest wall established by means of joint-play and/or end-play palpation.

24-h pH-metry: 24-h pH monitoring measures with a single sensor located above the lower esophageal sphincter (LES) a reflux event and the association of the reflux event with symptoms can also be ascertained from the tracing; manometry: esophageal manometry measures mean pressure of the lower esophageal sphincter and any degree of hypomotility and dysmotility in the esophagus.

LR+, positive likelihood ratio calculated sensitivity/1 - specificity; LR-, negative likelihood ratio calculated 1 - sensitivity/specificity; diagnostic test accuracy. Very good: LR + \>10, LR- \<0.1; good: LR + 5 to 10, LR- 0.1 to 0.2; fair: LR + 2 to 5, LR- 0.2 to 0.5; poor: LR + 1 to 2, LR- 0.5 to 1.

Reference tests are as follows. Endoscopic classification: LA classification: grade A, ≥1 mucosal break ≤5 mm, that does not extend between the tops of two mucosal folds; grade B, ≥1 mucosal break \>5 mm long that does not extend between the tops of two mucosal folds; grade C, ≥1 mucosal break that is continuous between the tops of two or more mucosal folds but which involves \<75% of the circumference; grade D, ≥1 mucosal break which involves at least 75% of the esophageal circumference \[[@B52]\]. Savary-Miller System: grade I, single or isolated erosive lesion(s) affecting only one longitudinal fold; grade II, multiple erosive lesions, non-circumferential, affecting more than one longitudinal fold, with or without confluence; grade III, circumferential erosive lesions; grade IV, chronic lesions: ulcer(s), stricture(s) and/or short esophagus. Alone or associated with lesions of grades 1 to 3; grade V, columnar epithelium in continuity with the Z line, non-circular, star-shaped, or circumferential. Alone or associated with lesions of grades 1 to 4 \[[@B53]\]. Hentzel-Dent grades: grade 0, no mucosal abnormalities; grade 1, no macroscopic lesions but erythema, hyperemia, or mucosal friability; grade 2, superficial erosions involving \<10% of mucosal surface of the last 5 cm of esophageal squamous mucosa; grade 3, superficial erosions or ulceration involving 10% to 50% of the mucosal surface of the last 5 cm of esophageal squamous mucosa; grade 4, deep peptide ulceration anywhere in the esophagus or confluent erosion of \>50% of the mucosal surface of the last 5 cm of esophageal squamous mucosa \[[@B54]\]. pH-metry: De Meester criteria: (1) total number of reflux episodes; (2) number of reflux episodes with pH \<4 for more than 5 minutes; (3) duration of the longest episode; (4) percentage total time pH \<4; (5) percentage upright time pH \<4; and 6) percentage recumbent time pH \<4. \[[@B55]\]. Manometry: Spechler criteria: diagnosis of ineffective esophageal motility, nutcracker esophagus, spasm, achalasia based on: basal lower esophageal sphincter pressure, relaxation, wave progression, distal wave amplitude \[[@B56]\].

*ACQ* Agoraphobia Cognitions Questionnaire, *ADIS-R* structured interview by psychologist, recommended interview protocol for panic research, *CVD* cardiovascular disease, *DSM-IV (ADIS-IV)* Anxiety Disorders Interview Schedule, *GERD* gastroesophageal reflux disease, *GP* general practitioner, *GPE* Ghillibert probability estimate (sum of partial probabilities for exact numbers of reflux associated symptoms within the context of the total number of symptoms), *HDR* high-degree response, *EoE* eosinophilic esophagitis (typical abnormal EoE endoscopic findings (rings or furrows)), *IHD* ischemic heart disease, *McGill sensory* McGill Pain Questionnaire sensory, *MIA* Mobility Inventory for Agoraphobia, *MINI* Mini International Neuropsychiatric Interview (gold standard for anxiety disorders), *NPV* negative predictive value, *PPV* positive predictive value, *SI* symptom index (calculated as the proportion of chest pain symptoms (pH \<4) divided by the number of chest pain episodes recorded, expressed as a percentage), *SIS* symptom index score (calculated by adding the reported daily severity (mild = 1; moderate = 2; severe = 3; and disabling = 4) multiplied by the reported daily frequency values during each week).
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